Visible node/edge number:
Node colors:
Node labels:

show label of nodes with degree >=

Node sizes:
Edge colors:
Edge widths factor:
Layout:

gravity >=

edgeLength =

GRN in network:

Notice: IE browser need to manually refresh (F5) this page after resetting the network.

This regulatory network was inferred from the input dataset. The miRNAs and mRNAs are presented as round and rectangle nodes respectively. The numerical value popped up upon mouse over the gene node is the log2 transformed fold-change of the gene expression between the two groups. All of the nodes are clickable, and the detailed information of the miRNAs/mRNAs and related cancer pathway will be displayed in another window. The edges between nodes are supported by both interactions (predicted or experimentally verified) and correlations learnt from cancer dataset. The numerical value popped up upon mouse over the edge is the correlation beat value (effect size) between the two nodes. The experimental evidences of the edges reported in previous cancer studies are highlighted by red/orange color. All of these information can be accessed by the "mouse-over" action. This network shows a full map of the miRNA-mRNA regulation of the input gene list(s), and the hub miRNAs (with the high network degree/betweenness centrality) would be the potential cancer drivers or tumor suppressors. The full result table can be accessed in the "Regulations" tab.

"miRNACancerMAP" is also a network visualization tool for users to draw their regulatory network by personal customization. Users can set the complexity of the network by limiting the number of nodes or edges. And the color of the nodes can be defined by different categories of the mRNAs and miRNAs, such as Gene-Ontology, pathway, and expression status. Users can also select to use network degree or network betweenness centrality to define the node size. And edges can be black or colored by the correlation. Purple edge means negative correlation (mostly found between miRNA and mRNA), and blue edge means positive correlation (found in PPI or miRNA-miRNA sponge effect). We can also add the protein-protein interactions (PPI) into the network. This result will show the cluster of genes regulated by some specific miRNAs. Additionally, miRNA-miRNA edges can be added by the "miRNA sponge" button, presenting some clusters of miRNAs that have the interactions via sponge effect.

miRNA-gene regulations

(Download full result)

Num microRNA           Gene miRNA log2FC miRNA pvalue Gene log2FC Gene pvalue Interaction Correlation beta Correlation P-value PMID Reported in cancer studies
1 hsa-miR-342-3p AADAC 1.22 0 -4.47 0 miRanda -0.67 0 NA
2 hsa-miR-361-5p AAK1 -0.1 0.09543 -0.32 0 PITA -0.21 0 NA
3 hsa-miR-590-3p AASS 1.27 0 -1.98 0 MirTarget; miRanda -0.38 0 NA
4 hsa-miR-27a-5p ABAT -1.24 0 0.64 0.00201 miRNATAP -0.31 0 NA
5 hsa-miR-590-3p ABAT 1.27 0 0.64 0.00201 PITA; miRanda -0.47 0 NA
6 hsa-miR-361-5p ABCA1 -0.1 0.09543 -1.41 0 miRanda; mirMAP -0.27 4.0E-5 NA
7 hsa-miR-454-3p ABCA1 1.28 0 -1.41 0 miRNATAP -0.15 0 NA
8 hsa-miR-590-3p ABCA1 1.27 0 -1.41 0 miRanda -0.16 0 NA
9 hsa-miR-590-3p ABCA10 1.27 0 -4.63 0 miRanda; mirMAP -0.81 0 NA
10 hsa-miR-342-3p ABCA13 1.22 0 -1.78 0 miRanda -0.5 0 NA
11 hsa-miR-432-5p ABCA3 -1.28 0 0.75 0 MirTarget -0.19 0 NA
12 hsa-miR-590-3p ABCA5 1.27 0 -1.92 0 MirTarget; miRanda; mirMAP -0.21 0 NA
13 hsa-miR-342-3p ABCA6 1.22 0 -3.37 0 miRanda -0.3 0 NA
14 hsa-miR-590-3p ABCA6 1.27 0 -3.37 0 MirTarget; miRanda -0.59 0 NA
15 hsa-miR-590-3p ABCA8 1.27 0 -5.12 0 miRanda -1.07 0 NA
16 hsa-miR-590-3p ABCA9 1.27 0 -4.44 0 miRanda -0.76 0 NA
17 hsa-miR-590-3p ABCB1 1.27 0 -2.55 0 miRanda -0.41 0 NA
18 hsa-miR-361-5p ABCB10 -0.1 0.09543 0.24 0.00025 MirTarget; miRanda -0.16 4.0E-5 NA
19 hsa-miR-590-3p ABCB5 1.27 0 -4.85 0 miRanda; mirMAP -0.91 0 NA
20 hsa-miR-590-3p ABCC13 1.27 0 2.29 0 miRanda -0.27 0.01292 NA
21 hsa-miR-590-3p ABCC3 1.27 0 -0.09 0.58506 mirMAP -0.19 3.0E-5 NA
22 hsa-miR-664a-3p ABCC4 -0.24 0.01971 -0.06 0.70716 mirMAP -0.31 0 NA
23 hsa-miR-432-5p ABCC5 -1.28 0 0.8 0 MirTarget -0.1 0.00065 NA
24 hsa-miR-590-3p ABCC6P1 1.27 0 -2.44 0 miRanda -0.48 0 NA
25 hsa-miR-342-3p ABCC9 1.22 0 -2.42 0 miRanda -0.26 0 NA
26 hsa-miR-590-3p ABCC9 1.27 0 -2.42 0 miRanda; mirMAP -0.37 0 NA
27 hsa-miR-590-3p ABCD2 1.27 0 -4.13 0 MirTarget; miRanda; mirMAP -0.25 0.00039 NA
28 hsa-miR-369-3p ABCD3 0.09 0.4852 0.36 0.0002 MirTarget; PITA; miRNATAP -0.16 0 NA
29 hsa-miR-590-3p ABCG2 1.27 0 -1.95 0 miRanda; mirMAP -0.51 0 NA
30 hsa-miR-410-3p ABHD10 -0.62 4.0E-5 0.03 0.59624 MirTarget -0.11 0 NA
31 hsa-miR-590-3p ABHD12B 1.27 0 -0.34 0.2539 miRanda; mirMAP; miRNATAP -0.33 6.0E-5 NA
32 hsa-miR-590-3p ABHD15 1.27 0 -0.6 0 miRanda -0.13 0 NA
33 hsa-miR-214-3p ABHD2 -0.52 0.00021 0.45 0.00053 miRNATAP -0.12 0.00013 NA
34 hsa-miR-361-5p ABHD2 -0.1 0.09543 0.45 0.00053 PITA; mirMAP -0.59 0 NA
35 hsa-miR-432-5p ABHD2 -1.28 0 0.45 0.00053 mirMAP -0.1 0.00105 NA
36 hsa-miR-590-3p ABHD2 1.27 0 0.45 0.00053 miRanda; mirMAP -0.15 2.0E-5 NA
37 hsa-miR-590-3p ABI3BP 1.27 0 -2.67 0 miRanda -0.44 0 NA
38 hsa-miR-361-5p ABL2 -0.1 0.09543 0.21 0.00092 mirMAP -0.16 2.0E-5 NA
39 hsa-miR-590-3p ABLIM1 1.27 0 -1.69 0 miRanda; mirMAP -0.13 5.0E-5 NA
40 hsa-miR-590-3p ACAD11 1.27 0 -1.05 0 miRanda; mirMAP -0.14 0 NA
41 hsa-miR-590-3p ACADL 1.27 0 -5.19 0 miRanda -0.63 0 NA
42 hsa-miR-24-2-5p ACADSB -0.22 0.05957 -0.52 0.002 MirTarget -0.41 0 NA
43 hsa-miR-361-5p ACADSB -0.1 0.09543 -0.52 0.002 MirTarget; miRanda; miRNATAP -0.46 0 NA
44 hsa-miR-590-3p ACADSB 1.27 0 -0.52 0.002 MirTarget; miRanda; mirMAP -0.44 0 NA
45 hsa-miR-664a-3p ACAN -0.24 0.01971 2.73 0 mirMAP -0.32 3.0E-5 NA
46 hsa-miR-361-5p ACAP2 -0.1 0.09543 -0.39 0 miRanda; mirMAP; miRNATAP -0.2 0 NA
47 hsa-miR-532-3p ACBD4 -0.4 0.00687 -0.42 0.00049 miRNATAP -0.3 0 NA
48 hsa-miR-361-5p ACBD5 -0.1 0.09543 0.06 0.42369 miRanda -0.24 0 NA
49 hsa-miR-342-3p ACER3 1.22 0 -0.64 0 miRanda -0.1 0.00023 NA
50 hsa-miR-361-5p ACER3 -0.1 0.09543 -0.64 0 mirMAP -0.24 0.0002 NA
51 hsa-miR-214-3p ACLY -0.52 0.00021 0.43 0 MirTarget -0.13 0 NA
52 hsa-miR-361-5p ACLY -0.1 0.09543 0.43 0 miRNAWalker2 validate; miRanda -0.29 0 NA
53 hsa-miR-590-3p ACOT1 1.27 0 -0.54 0 miRanda -0.22 0 NA
54 hsa-miR-590-3p ACOT2 1.27 0 -0.5 0 miRanda -0.21 0 NA
55 hsa-miR-590-3p ACOX2 1.27 0 -0.76 0.001 miRanda -0.51 0 NA
56 hsa-miR-454-3p ACSL1 1.28 0 -2.41 0 MirTarget -0.18 0 NA
57 hsa-miR-590-3p ACSL1 1.27 0 -2.41 0 miRanda -0.15 0.00096 NA
58 hsa-miR-342-3p ACSL4 1.22 0 -1.48 0 MirTarget; miRanda -0.26 0 NA
59 hsa-miR-454-3p ACSL4 1.28 0 -1.48 0 MirTarget; miRNATAP -0.16 0 NA
60 hsa-miR-664a-3p ACSL4 -0.24 0.01971 -1.48 0 mirMAP -0.15 0.00026 NA
61 hsa-miR-590-3p ACSM5 1.27 0 -3.68 0 miRanda -0.6 0 NA
62 hsa-miR-590-3p ACSS3 1.27 0 -1.68 0 miRanda -0.38 0 NA
63 hsa-miR-590-3p ACTC1 1.27 0 -1.25 0 miRanda -0.14 0.04278 NA
64 hsa-miR-590-3p ACTG2 1.27 0 -3.41 0 miRanda -0.32 4.0E-5 NA
65 hsa-miR-26a-2-3p ACTN2 -0.14 0.17854 0.57 0.06176 mirMAP -0.21 0.03349 NA
66 hsa-miR-432-5p ACTR3C -1.28 0 0.17 0.10546 mirMAP -0.12 1.0E-5 NA
67 hsa-miR-590-3p ACVR1 1.27 0 -0.46 0 miRanda -0.11 0 NA
68 hsa-miR-532-3p ACVR1B -0.4 0.00687 0.15 0.02139 PITA; miRNATAP -0.11 0 NA
69 hsa-miR-590-3p ACVR1C 1.27 0 -5.2 0 miRanda -0.58 0 NA
70 hsa-miR-454-3p ACVR2A 1.28 0 -0.96 0 miRNATAP -0.14 0 NA
71 hsa-miR-590-3p ACVR2A 1.27 0 -0.96 0 MirTarget; PITA; miRanda; miRNATAP -0.13 0 NA
72 hsa-miR-342-3p ACVRL1 1.22 0 -0.99 0 miRanda -0.16 0 NA
73 hsa-miR-361-5p ADAL -0.1 0.09543 -0.36 0 miRanda -0.16 0.00036 NA
74 hsa-miR-361-5p ADAM10 -0.1 0.09543 -0.37 0.00057 miRanda -0.51 0 NA
75 hsa-miR-361-5p ADAM12 -0.1 0.09543 1.3 0 miRanda -0.54 0 NA
76 hsa-miR-361-5p ADAM19 -0.1 0.09543 1.6 0 miRanda -0.25 0.0017 NA
77 hsa-miR-664a-3p ADAM19 -0.24 0.01971 1.6 0 MirTarget -0.36 0 NA
78 hsa-miR-361-5p ADAM22 -0.1 0.09543 -1.22 0 mirMAP -0.33 0.0048 NA
79 hsa-miR-454-3p ADAM22 1.28 0 -1.22 0 mirMAP -0.25 0 NA
80 hsa-miR-590-3p ADAM22 1.27 0 -1.22 0 MirTarget; PITA; miRanda; mirMAP -0.35 0 NA
81 hsa-miR-590-3p ADAM23 1.27 0 -0.63 0.00091 miRanda -0.28 0 NA
82 hsa-miR-590-3p ADAM33 1.27 0 -3.44 0 miRanda -0.86 0 NA
83 hsa-miR-342-3p ADAM9 1.22 0 -0.03 0.77501 miRanda -0.14 0 NA
84 hsa-miR-342-3p ADAMTS1 1.22 0 -2.52 0 miRanda -0.41 0 NA
85 hsa-miR-590-3p ADAMTS1 1.27 0 -2.52 0 miRanda -0.3 0 NA
86 hsa-miR-362-5p ADAMTS12 -0.25 0.07261 0.1 0.62063 mirMAP -0.35 0 NA
87 hsa-miR-532-3p ADAMTS13 -0.4 0.00687 0.49 0.00058 miRNATAP -0.3 0 NA
88 hsa-miR-590-3p ADAMTS16 1.27 0 -0.28 0.29506 miRanda; mirMAP -0.57 0 NA
89 hsa-miR-362-5p ADAMTS17 -0.25 0.07261 0.43 0.0095 mirMAP -0.12 0.00451 NA
90 hsa-miR-454-3p ADAMTS18 1.28 0 -2.9 0 miRNATAP -0.45 0 NA
91 hsa-miR-590-3p ADAMTS18 1.27 0 -2.9 0 PITA; miRanda; miRNATAP -0.55 0 NA
92 hsa-miR-590-3p ADAMTS19 1.27 0 0.71 0.02881 PITA; miRanda; mirMAP; miRNATAP -0.31 0.00066 NA
93 hsa-miR-590-3p ADAMTS5 1.27 0 -3.55 0 PITA; miRanda; miRNATAP -0.48 0 NA
94 hsa-miR-664a-3p ADAMTS6 -0.24 0.01971 1.1 0 mirMAP -0.21 0 NA
95 hsa-miR-143-5p ADAMTS8 -1.09 0 -1.48 0 MirTarget -0.14 0.0026 NA
96 hsa-miR-590-3p ADAMTS8 1.27 0 -1.48 0 miRanda -0.4 0 NA
97 hsa-miR-590-3p ADAMTS9 1.27 0 -1.55 0 miRanda -0.15 9.0E-5 NA
98 hsa-miR-590-3p ADAMTSL1 1.27 0 -1.1 0 miRanda; mirMAP -0.26 0 NA
99 hsa-miR-590-3p ADAMTSL3 1.27 0 -1.39 0 miRanda -0.23 0 NA
100 hsa-miR-590-3p ADAMTSL5 1.27 0 0.43 0.02335 miRanda -0.38 0 NA
101 hsa-miR-342-3p ADARB1 1.22 0 -0.6 0 miRanda -0.13 0 NA
102 hsa-miR-590-3p ADARB2 1.27 0 -1.08 1.0E-5 miRanda -0.21 0.0013 NA
103 hsa-miR-214-3p ADCY1 -0.52 0.00021 -0.05 0.84149 mirMAP -0.12 0.03717 NA
104 hsa-miR-369-3p ADCY1 0.09 0.4852 -0.05 0.84149 PITA; miRNATAP -0.17 0.01028 NA
105 hsa-miR-454-3p ADCY1 1.28 0 -0.05 0.84149 MirTarget; miRNATAP -0.19 0.00127 NA
106 hsa-miR-342-3p ADCY2 1.22 0 -0.73 0.00385 miRanda -0.39 0 NA
107 hsa-miR-454-3p ADCY2 1.28 0 -0.73 0.00385 miRNATAP -0.33 0 NA
108 hsa-miR-590-3p ADCY2 1.27 0 -0.73 0.00385 mirMAP -0.23 0.00088 NA
109 hsa-miR-342-3p ADCY3 1.22 0 -0.58 0 miRanda -0.14 0 NA
110 hsa-miR-532-3p ADCY6 -0.4 0.00687 -0.63 0 PITA -0.17 0 NA
111 hsa-miR-590-3p ADCY6 1.27 0 -0.63 0 miRanda -0.26 0 NA
112 hsa-miR-361-5p ADCY9 -0.1 0.09543 0.12 0.23839 miRanda -0.25 2.0E-5 NA
113 hsa-miR-590-3p ADCY9 1.27 0 0.12 0.23839 miRanda -0.22 0 NA
114 hsa-miR-590-3p ADCYAP1 1.27 0 -0.67 0.02162 MirTarget; PITA; miRanda; miRNATAP -0.3 0.0002 NA
115 hsa-miR-664a-3p ADCYAP1 -0.24 0.01971 -0.67 0.02162 MirTarget -0.24 0.01529 NA
116 hsa-miR-362-5p ADCYAP1R1 -0.25 0.07261 -4.27 0 MirTarget; TargetScan -0.16 0.01761 NA
117 hsa-miR-590-3p ADD1 1.27 0 -0.47 0 MirTarget; PITA; miRanda; miRNATAP -0.15 0 NA
118 hsa-miR-590-3p ADD3 1.27 0 -1.66 0 MirTarget; PITA; miRanda; mirMAP -0.12 0.00108 NA
119 hsa-miR-664a-3p ADD3 -0.24 0.01971 -1.66 0 MirTarget -0.11 0.01192 NA
120 hsa-miR-590-3p ADH1A 1.27 0 -6.13 0 miRanda -0.94 0 NA
121 hsa-miR-342-3p ADH1B 1.22 0 -7.23 0 miRanda -0.54 2.0E-5 NA
122 hsa-miR-590-3p ADH1B 1.27 0 -7.23 0 miRanda; mirMAP -1.26 0 NA
123 hsa-miR-590-3p ADH1C 1.27 0 -5.26 0 miRanda -0.93 0 NA
124 hsa-miR-590-3p ADH4 1.27 0 -4.75 0 miRanda; mirMAP -0.53 0 NA
125 hsa-miR-342-3p ADI1 1.22 0 -0.35 3.0E-5 miRanda -0.14 0 NA
126 hsa-miR-590-3p ADIPOQ 1.27 0 -7.2 0 PITA; miRanda; mirMAP -1.2 0 NA
127 hsa-miR-214-3p ADM2 -0.52 0.00021 2.41 0 mirMAP -0.2 0 NA
128 hsa-miR-432-5p ADM2 -1.28 0 2.41 0 mirMAP -0.26 0 NA
129 hsa-miR-361-5p ADNP -0.1 0.09543 0.29 6.0E-5 miRanda -0.31 0 NA
130 hsa-miR-342-3p ADORA2B 1.22 0 -0.76 0 miRanda -0.34 0 NA
131 hsa-miR-342-3p ADRA1A 1.22 0 -4.75 0 miRanda -0.46 0 NA
132 hsa-miR-342-3p ADRA2B 1.22 0 -1.36 0 miRanda -0.24 0 NA
133 hsa-miR-342-3p ADRB1 1.22 0 -2.83 0 PITA; miRanda -0.29 2.0E-5 NA
134 hsa-miR-590-3p ADRB1 1.27 0 -2.83 0 PITA; miRanda; mirMAP; miRNATAP -0.4 0 NA
135 hsa-miR-590-3p ADRB2 1.27 0 -3.09 0 MirTarget; PITA; miRanda -0.47 0 NA
136 hsa-miR-361-5p ADSS -0.1 0.09543 0.81 0 miRanda -0.2 0 NA
137 hsa-miR-362-5p AFAP1 -0.25 0.07261 -0.21 0.00289 mirMAP -0.1 0 NA
138 hsa-miR-664a-3p AFAP1 -0.24 0.01971 -0.21 0.00289 mirMAP -0.11 0 NA
139 hsa-miR-590-3p AFAP1L2 1.27 0 -1.15 0 miRanda; mirMAP -0.33 0 NA
140 hsa-miR-454-3p AFF1 1.28 0 -0.82 0 MirTarget -0.14 0 NA
141 hsa-miR-590-3p AFF1 1.27 0 -0.82 0 MirTarget; PITA; miRanda; miRNATAP -0.21 0 NA
142 hsa-miR-342-3p AFF2 1.22 0 -1.78 0 mirMAP -0.32 0 NA
143 hsa-miR-590-3p AFF2 1.27 0 -1.78 0 PITA; miRanda; mirMAP; miRNATAP -0.17 0.00099 NA
144 hsa-miR-664a-3p AFF2 -0.24 0.01971 -1.78 0 mirMAP -0.19 0.0026 NA
145 hsa-miR-369-3p AFF3 0.09 0.4852 -0.33 0.2554 MirTarget; PITA; miRNATAP -0.29 0.00018 NA
146 hsa-miR-590-3p AFF3 1.27 0 -0.33 0.2554 PITA; miRanda; mirMAP; miRNATAP -0.67 0 NA
147 hsa-miR-361-5p AFF4 -0.1 0.09543 -0.28 0.00153 miRanda -0.48 0 NA
148 hsa-miR-590-3p AFF4 1.27 0 -0.28 0.00153 MirTarget; PITA; miRanda; mirMAP; miRNATAP -0.15 0 NA
149 hsa-miR-342-3p AGAP11 1.22 0 -2.72 0 miRanda -0.12 0.00734 NA
150 hsa-miR-193a-5p AGAP3 -1.15 0 0.28 0.00021 miRNATAP -0.11 8.0E-5 NA

Over-represented Gene Ontology Biological Process

NumGOOverlapSizeP ValueAdj. P Value
1 NEUROGENESIS 492 1402 3.671e-41 1.708e-37
2 CARDIOVASCULAR SYSTEM DEVELOPMENT 320 788 1.62e-40 2.512e-37
3 CIRCULATORY SYSTEM DEVELOPMENT 320 788 1.62e-40 2.512e-37
4 TISSUE DEVELOPMENT 508 1518 3.294e-36 3.831e-33
5 REGULATION OF MULTICELLULAR ORGANISMAL DEVELOPMENT 546 1672 1.047e-35 9.741e-33
6 CELL DEVELOPMENT 479 1426 1.579e-34 1.225e-31
7 REGULATION OF CELL DIFFERENTIATION 487 1492 1.163e-31 7.733e-29
8 REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS 363 1021 1.737e-31 1.01e-28
9 VASCULATURE DEVELOPMENT 205 469 2.828e-31 1.462e-28
10 ORGAN MORPHOGENESIS 311 841 1.959e-30 9.117e-28
11 POSITIVE REGULATION OF DEVELOPMENTAL PROCESS 388 1142 5.313e-29 2.247e-26
12 POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 453 1395 7.63e-29 2.959e-26
13 BLOOD VESSEL MORPHOGENESIS 167 364 1.319e-28 4.72e-26
14 CELLULAR COMPONENT MORPHOGENESIS 320 900 8.727e-28 2.901e-25
15 LOCOMOTION 375 1114 3.759e-27 1.166e-24
16 MOVEMENT OF CELL OR SUBCELLULAR COMPONENT 416 1275 6.177e-27 1.796e-24
17 ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS 331 957 2.721e-26 7.448e-24
18 RESPONSE TO ENDOGENOUS STIMULUS 457 1450 6.217e-26 1.607e-23
19 CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 206 513 1.491e-25 3.652e-23
20 CELL PROJECTION ORGANIZATION 314 902 1.7e-25 3.954e-23
21 BIOLOGICAL ADHESION 348 1032 2.303e-25 5.103e-23
22 NEURON DIFFERENTIATION 306 874 2.533e-25 5.357e-23
23 SKELETAL SYSTEM DEVELOPMENT 188 455 3.761e-25 7.609e-23
24 REGULATION OF CELL DEVELOPMENT 295 836 4.743e-25 9.196e-23
25 REGULATION OF NEURON DIFFERENTIATION 216 554 9.384e-25 1.747e-22
26 REGULATION OF CELLULAR COMPONENT MOVEMENT 275 771 3.398e-24 6.082e-22
27 POSITIVE REGULATION OF CELL COMMUNICATION 469 1532 1.267e-23 2.183e-21
28 REGULATION OF NERVOUS SYSTEM DEVELOPMENT 267 750 2.245e-23 3.73e-21
29 CENTRAL NERVOUS SYSTEM DEVELOPMENT 299 872 3.937e-23 6.316e-21
30 REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 496 1656 9.893e-23 1.534e-20
31 CELLULAR RESPONSE TO ENDOGENOUS STIMULUS 333 1008 1.323e-22 1.986e-20
32 EMBRYO DEVELOPMENT 303 894 1.547e-22 2.25e-20
33 ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY 248 689 1.617e-22 2.28e-20
34 HEART DEVELOPMENT 185 466 2.169e-22 2.968e-20
35 EPITHELIUM DEVELOPMENT 315 945 4.211e-22 5.599e-20
36 POSITIVE REGULATION OF MOLECULAR FUNCTION 526 1791 4.728e-22 6.111e-20
37 REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 524 1784 5.61e-22 7.056e-20
38 REGULATION OF CELL MORPHOGENESIS 208 552 9.502e-22 1.163e-19
39 UROGENITAL SYSTEM DEVELOPMENT 133 299 1.579e-21 1.884e-19
40 CELL MOTILITY 284 835 2.021e-21 2.294e-19
41 LOCALIZATION OF CELL 284 835 2.021e-21 2.294e-19
42 NEURON DEVELOPMENT 243 687 6.238e-21 6.911e-19
43 REGULATION OF TRANSPORT 524 1804 7.669e-21 8.299e-19
44 POSITIVE REGULATION OF CELL DIFFERENTIATION 279 823 7.936e-21 8.392e-19
45 REGULATION OF NEURON PROJECTION DEVELOPMENT 164 408 1.257e-20 1.299e-18
46 TUBE DEVELOPMENT 205 552 1.374e-20 1.39e-18
47 EMBRYONIC MORPHOGENESIS 201 539 1.904e-20 1.885e-18
48 TISSUE MORPHOGENESIS 199 533 2.532e-20 2.455e-18
49 CELL PART MORPHOGENESIS 226 633 4.179e-20 3.968e-18
50 SENSORY ORGAN DEVELOPMENT 187 493 4.978e-20 4.632e-18
51 POSITIVE REGULATION OF CELL DEVELOPMENT 181 472 5.189e-20 4.734e-18
52 REGULATION OF CELL PROJECTION ORGANIZATION 205 558 5.865e-20 5.248e-18
53 POSITIVE REGULATION OF GENE EXPRESSION 503 1733 6.312e-20 5.541e-18
54 NEURON PROJECTION DEVELOPMENT 201 545 8.239e-20 7.099e-18
55 POSITIVE REGULATION OF NEURON DIFFERENTIATION 131 306 1.831e-19 1.549e-17
56 NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS 268 801 3.629e-19 3.016e-17
57 REGULATION OF PHOSPHORUS METABOLIC PROCESS 472 1618 3.733e-19 3.047e-17
58 NEGATIVE REGULATION OF RESPONSE TO STIMULUS 409 1360 4.279e-19 3.433e-17
59 BEHAVIOR 191 516 4.426e-19 3.49e-17
60 NEGATIVE REGULATION OF CELL COMMUNICATION 367 1192 5.6e-19 4.343e-17
61 ANGIOGENESIS 126 293 5.745e-19 4.382e-17
62 REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 139 337 7.77e-19 5.831e-17
63 HEAD DEVELOPMENT 242 709 1.325e-18 9.786e-17
64 REGULATION OF CELL PROLIFERATION 440 1496 1.448e-18 1.052e-16
65 POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 167 437 2.188e-18 1.543e-16
66 NEURON PROJECTION MORPHOGENESIS 157 402 2.168e-18 1.543e-16
67 CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION 147 368 2.487e-18 1.727e-16
68 CONNECTIVE TISSUE DEVELOPMENT 93 194 4.489e-18 3.072e-16
69 SINGLE ORGANISM BEHAVIOR 151 384 4.698e-18 3.168e-16
70 REGULATION OF MEMBRANE POTENTIAL 139 343 4.848e-18 3.223e-16
71 POSITIVE REGULATION OF CATALYTIC ACTIVITY 443 1518 5.06e-18 3.316e-16
72 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 315 1004 1.141e-17 7.374e-16
73 POSITIVE REGULATION OF BIOSYNTHETIC PROCESS 509 1805 1.867e-17 1.19e-15
74 RESPONSE TO OXYGEN CONTAINING COMPOUND 406 1381 3.981e-17 2.503e-15
75 INTRACELLULAR SIGNAL TRANSDUCTION 450 1572 1.122e-16 6.961e-15
76 POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 348 1152 1.198e-16 7.335e-15
77 POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION 124 303 1.242e-16 7.503e-15
78 RESPONSE TO GROWTH FACTOR 173 475 1.308e-16 7.805e-15
79 POSITIVE REGULATION OF RESPONSE TO STIMULUS 534 1929 1.365e-16 8.041e-15
80 REGULATION OF PROTEIN MODIFICATION PROCESS 482 1710 1.684e-16 9.793e-15
81 POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT 102 232 2.087e-16 1.199e-14
82 NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS 305 983 2.128e-16 1.207e-14
83 EAR DEVELOPMENT 90 195 3.111e-16 1.744e-14
84 CELLULAR RESPONSE TO ORGANIC SUBSTANCE 513 1848 3.476e-16 1.926e-14
85 REGULATION OF GROWTH 214 633 4.584e-16 2.509e-14
86 EMBRYONIC ORGAN DEVELOPMENT 152 406 6.161e-16 3.333e-14
87 RESPONSE TO LIPID 279 888 7.724e-16 4.131e-14
88 POSITIVE REGULATION OF TRANSPORT 291 936 8.193e-16 4.332e-14
89 REGULATION OF DEVELOPMENTAL GROWTH 118 289 8.303e-16 4.341e-14
90 REGULATION OF GTPASE ACTIVITY 223 673 1.342e-15 6.938e-14
91 POSITIVE REGULATION OF LOCOMOTION 155 420 1.371e-15 7.009e-14
92 GROWTH 152 410 1.647e-15 8.33e-14
93 RESPONSE TO HORMONE 279 893 1.696e-15 8.485e-14
94 EMBRYONIC ORGAN MORPHOGENESIS 114 279 2.403e-15 1.19e-13
95 POSITIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 314 1036 2.585e-15 1.253e-13
96 POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 314 1036 2.585e-15 1.253e-13
97 NEGATIVE REGULATION OF CELL PROLIFERATION 214 643 3.042e-15 1.459e-13
98 CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND 254 799 3.591e-15 1.705e-13
99 POSITIVE REGULATION OF HYDROLASE ACTIVITY 280 905 5.82e-15 2.735e-13
100 CARTILAGE DEVELOPMENT 72 147 6.291e-15 2.927e-13
101 RESPONSE TO ORGANIC CYCLIC COMPOUND 282 917 1.062e-14 4.894e-13
102 NEGATIVE REGULATION OF CELL DIFFERENTIATION 203 609 1.344e-14 6.132e-13
103 CELL CELL SIGNALING 243 767 2.231e-14 1.008e-12
104 MORPHOGENESIS OF AN EPITHELIUM 146 400 2.607e-14 1.166e-12
105 REGULATION OF SYSTEM PROCESS 175 507 2.804e-14 1.243e-12
106 APPENDAGE DEVELOPMENT 78 169 2.921e-14 1.259e-12
107 PROTEIN PHOSPHORYLATION 287 944 2.923e-14 1.259e-12
108 LIMB DEVELOPMENT 78 169 2.921e-14 1.259e-12
109 TUBE MORPHOGENESIS 124 323 3.639e-14 1.553e-12
110 REGULATION OF CELLULAR LOCALIZATION 367 1277 5.635e-14 2.383e-12
111 MESENCHYME DEVELOPMENT 84 190 6.262e-14 2.625e-12
112 DEVELOPMENTAL GROWTH 126 333 7.839e-14 3.257e-12
113 MUSCLE STRUCTURE DEVELOPMENT 153 432 1.12e-13 4.611e-12
114 NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS 182 541 1.26e-13 5.1e-12
115 NEGATIVE REGULATION OF PHOSPHATE METABOLIC PROCESS 182 541 1.26e-13 5.1e-12
116 REGULATION OF HYDROLASE ACTIVITY 377 1327 1.495e-13 5.998e-12
117 REGULATION OF ION TRANSPORT 195 592 1.625e-13 6.461e-12
118 REGULATION OF KINASE ACTIVITY 242 776 1.73e-13 6.822e-12
119 MODULATION OF SYNAPTIC TRANSMISSION 116 301 1.782e-13 6.968e-12
120 STEM CELL DIFFERENTIATION 83 190 1.978e-13 7.67e-12
121 GLAND DEVELOPMENT 142 395 2.316e-13 8.906e-12
122 REGULATION OF MAPK CASCADE 212 660 2.385e-13 9.098e-12
123 REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 88 207 2.51e-13 9.496e-12
124 REGULATION OF EPITHELIAL CELL PROLIFERATION 111 285 2.612e-13 9.801e-12
125 COGNITION 101 251 2.915e-13 1.085e-11
126 SKELETAL SYSTEM MORPHOGENESIS 86 201 3.031e-13 1.119e-11
127 POSITIVE REGULATION OF KINASE ACTIVITY 165 482 3.435e-13 1.259e-11
128 FOREBRAIN DEVELOPMENT 131 357 3.557e-13 1.293e-11
129 REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 94 229 4.826e-13 1.741e-11
130 RESPONSE TO STEROID HORMONE 168 497 7.083e-13 2.535e-11
131 CELLULAR RESPONSE TO HORMONE STIMULUS 182 552 9.659e-13 3.431e-11
132 NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 230 740 1.033e-12 3.642e-11
133 RESPONSE TO ABIOTIC STIMULUS 300 1024 1.151e-12 4.025e-11
134 CIRCULATORY SYSTEM PROCESS 132 366 1.237e-12 4.297e-11
135 SENSORY ORGAN MORPHOGENESIS 96 239 1.272e-12 4.383e-11
136 RESPONSE TO NITROGEN COMPOUND 259 859 1.545e-12 5.287e-11
137 SYNAPSE ORGANIZATION 67 145 1.753e-12 5.945e-11
138 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY 167 498 1.763e-12 5.945e-11
139 REGULATION OF OSSIFICATION 77 178 2.663e-12 8.914e-11
140 POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 262 876 3.014e-12 1.002e-10
141 MESENCHYMAL CELL DIFFERENTIATION 63 134 3.092e-12 1.02e-10
142 POSITIVE REGULATION OF DEVELOPMENTAL GROWTH 70 156 3.195e-12 1.043e-10
143 NEGATIVE REGULATION OF PHOSPHORYLATION 146 422 3.205e-12 1.043e-10
144 NEURON PROJECTION GUIDANCE 85 205 3.269e-12 1.056e-10
145 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 64 138 4.466e-12 1.433e-10
146 POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS 324 1135 4.756e-12 1.516e-10
147 PATTERN SPECIFICATION PROCESS 144 418 6.48e-12 2.051e-10
148 KIDNEY EPITHELIUM DEVELOPMENT 59 125 1.221e-11 3.84e-10
149 NEURON MIGRATION 54 110 1.321e-11 4.126e-10
150 EYE DEVELOPMENT 118 326 1.468e-11 4.555e-10
151 TAXIS 155 464 1.555e-11 4.791e-10
152 EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING 178 554 2.008e-11 6.146e-10
153 REGULATION OF CARTILAGE DEVELOPMENT 37 63 2.522e-11 7.669e-10
154 REGULATION OF TRANSMEMBRANE TRANSPORT 144 426 3.135e-11 9.473e-10
155 EAR MORPHOGENESIS 54 112 3.208e-11 9.631e-10
156 EPITHELIAL CELL DEVELOPMENT 77 186 3.695e-11 1.102e-09
157 POSITIVE REGULATION OF CELL PROLIFERATION 242 814 4.071e-11 1.207e-09
158 EMBRYONIC SKELETAL SYSTEM DEVELOPMENT 57 122 4.506e-11 1.327e-09
159 REGULATION OF CHONDROCYTE DIFFERENTIATION 30 46 4.662e-11 1.364e-09
160 REGULATION OF PHOSPHOLIPASE ACTIVITY 37 64 4.81e-11 1.399e-09
161 REGULATION OF BLOOD CIRCULATION 108 295 4.857e-11 1.404e-09
162 MORPHOGENESIS OF A BRANCHING STRUCTURE 71 167 4.932e-11 1.417e-09
163 CELL CELL ADHESION 190 608 6.109e-11 1.744e-09
164 CELLULAR RESPONSE TO LIPID 151 457 7.09e-11 2.012e-09
165 HEART MORPHOGENESIS 84 212 7.27e-11 2.05e-09
166 REGULATION OF CELL DEATH 397 1472 8.574e-11 2.403e-09
167 REGULATION OF SECRETION 212 699 9.847e-11 2.744e-09
168 RESPONSE TO MECHANICAL STIMULUS 83 210 1.091e-10 3.023e-09
169 TELENCEPHALON DEVELOPMENT 88 228 1.313e-10 3.616e-09
170 REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 102 278 1.438e-10 3.935e-09
171 REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY 89 232 1.501e-10 4.084e-09
172 REGULATION OF CELLULAR COMPONENT BIOGENESIS 228 767 1.539e-10 4.164e-09
173 RESPONSE TO WOUNDING 177 563 1.636e-10 4.4e-09
174 POSITIVE REGULATION OF ION TRANSPORT 90 236 1.706e-10 4.563e-09
175 NEGATIVE REGULATION OF GENE EXPRESSION 400 1493 1.84e-10 4.892e-09
176 POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY 32 53 2.043e-10 5.402e-09
177 REGULATION OF INTRACELLULAR TRANSPORT 191 621 2.391e-10 6.285e-09
178 EPITHELIAL CELL DIFFERENTIATION 159 495 2.446e-10 6.354e-09
179 REGULATION OF DENDRITE DEVELOPMENT 55 120 2.438e-10 6.354e-09
180 POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 68 162 2.458e-10 6.354e-09
181 CHEMICAL HOMEOSTASIS 253 874 2.723e-10 6.999e-09
182 NEGATIVE REGULATION OF LOCOMOTION 97 263 2.908e-10 7.435e-09
183 RESPONSE TO EXTERNAL STIMULUS 474 1821 2.97e-10 7.511e-09
184 REGULATION OF METAL ION TRANSPORT 114 325 2.957e-10 7.511e-09
185 BONE DEVELOPMENT 66 156 3.001e-10 7.547e-09
186 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 76 190 3.414e-10 8.54e-09
187 SYNAPTIC SIGNALING 140 424 3.675e-10 9.144e-09
188 RESPONSE TO ACID CHEMICAL 112 319 3.967e-10 9.817e-09
189 POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 48 100 4.757e-10 1.171e-08
190 DIGESTIVE SYSTEM DEVELOPMENT 63 148 5.581e-10 1.36e-08
191 POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS 397 1492 5.556e-10 1.36e-08
192 CHONDROCYTE DIFFERENTIATION 34 60 6.118e-10 1.483e-08
193 CELLULAR RESPONSE TO ACID CHEMICAL 71 175 6.15e-10 1.483e-08
194 POSITIVE REGULATION OF MAPK CASCADE 151 470 6.807e-10 1.633e-08
195 POSITIVE REGULATION OF GROWTH 89 238 6.94e-10 1.656e-08
196 DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS 49 104 7.076e-10 1.68e-08
197 REGULATION OF CELL ADHESION 191 629 7.611e-10 1.798e-08
198 REGULATION OF EPITHELIAL CELL MIGRATION 68 166 8.644e-10 2.031e-08
199 REGULATION OF ANATOMICAL STRUCTURE SIZE 151 472 9.493e-10 2.22e-08
200 REGULATION OF CHEMOTAXIS 72 180 9.854e-10 2.293e-08
201 REGULATION OF CATION TRANSMEMBRANE TRANSPORT 80 208 1.085e-09 2.511e-08
202 MEMBRANE DEPOLARIZATION 34 61 1.113e-09 2.564e-08
203 PHOSPHORYLATION 334 1228 1.123e-09 2.575e-08
204 REGULATION OF CYTOPLASMIC TRANSPORT 153 481 1.154e-09 2.632e-08
205 REGULATION OF VASCULATURE DEVELOPMENT 87 233 1.171e-09 2.658e-08
206 BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE 57 131 1.347e-09 3.042e-08
207 NEGATIVE REGULATION OF CELL DEATH 249 872 1.554e-09 3.493e-08
208 MUSCLE TISSUE DEVELOPMENT 98 275 1.99e-09 4.452e-08
209 RHYTHMIC PROCESS 104 298 2.416e-09 5.379e-08
210 ION TRANSPORT 340 1262 2.495e-09 5.528e-08
211 REGULATION OF CELL SUBSTRATE ADHESION 69 173 2.522e-09 5.561e-08
212 REGULATION OF ION HOMEOSTASIS 77 201 2.73e-09 5.992e-08
213 TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER 212 724 2.806e-09 6.13e-08
214 INNER EAR MORPHOGENESIS 44 92 2.874e-09 6.248e-08
215 MUSCLE ORGAN DEVELOPMENT 98 277 3.078e-09 6.662e-08
216 MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL 25 39 3.338e-09 7.19e-08
217 NEGATIVE REGULATION OF NITROGEN COMPOUND METABOLIC PROCESS 398 1517 3.437e-09 7.369e-08
218 RESPONSE TO OXYGEN LEVELS 107 311 3.522e-09 7.517e-08
219 ENDOTHELIUM DEVELOPMENT 43 90 4.505e-09 9.486e-08
220 MESONEPHROS DEVELOPMENT 43 90 4.505e-09 9.486e-08
221 NEURAL CREST CELL DIFFERENTIATION 38 75 4.473e-09 9.486e-08
222 REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 148 470 4.586e-09 9.611e-08
223 POSITIVE REGULATION OF OSSIFICATION 41 84 4.634e-09 9.669e-08
224 REGULATION OF HORMONE LEVELS 150 478 4.678e-09 9.718e-08
225 REGULATION OF HOMEOSTATIC PROCESS 142 447 4.995e-09 1.033e-07
226 RESPONSE TO ALCOHOL 120 362 5.056e-09 1.041e-07
227 REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 29 50 5.359e-09 1.098e-07
228 FAT CELL DIFFERENTIATION 48 106 5.42e-09 1.106e-07
229 REGULATION OF RESPONSE TO EXTERNAL STIMULUS 259 926 6.098e-09 1.239e-07
230 CELLULAR RESPONSE TO NITROGEN COMPOUND 156 505 7.689e-09 1.555e-07
231 REGULATION OF PROTEIN LOCALIZATION 264 950 8.342e-09 1.68e-07
232 HOMEOSTATIC PROCESS 354 1337 9.425e-09 1.89e-07
233 CELL SUBSTRATE ADHESION 65 164 9.693e-09 1.936e-07
234 REGULATION OF ORGAN MORPHOGENESIS 87 242 9.768e-09 1.942e-07
235 CELL PROJECTION ASSEMBLY 93 264 9.823e-09 1.945e-07
236 POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 62 154 1.043e-08 2.056e-07
237 NERVE DEVELOPMENT 35 68 1.064e-08 2.09e-07
238 POSITIVE REGULATION OF TRANSFERASE ACTIVITY 183 616 1.079e-08 2.1e-07
239 NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS 183 616 1.079e-08 2.1e-07
240 CARDIAC CHAMBER DEVELOPMENT 59 144 1.091e-08 2.115e-07
241 MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL 13 14 1.102e-08 2.129e-07
242 REGULATION OF LIPASE ACTIVITY 40 83 1.131e-08 2.171e-07
243 REGULATION OF AXONOGENESIS 66 168 1.134e-08 2.171e-07
244 REGULATION OF HEART CONTRACTION 81 221 1.153e-08 2.198e-07
245 LEARNING 55 131 1.222e-08 2.32e-07
246 NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION 138 437 1.243e-08 2.351e-07
247 NEGATIVE REGULATION OF GROWTH 85 236 1.303e-08 2.454e-07
248 REGULATION OF TRANSFERASE ACTIVITY 262 946 1.333e-08 2.502e-07
249 NEPHRON DEVELOPMENT 50 115 1.397e-08 2.61e-07
250 REGULATION OF CELL GROWTH 126 391 1.424e-08 2.651e-07
251 ADULT BEHAVIOR 56 135 1.514e-08 2.807e-07
252 EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS 43 93 1.553e-08 2.868e-07
253 REGULATION OF BODY FLUID LEVELS 155 506 1.603e-08 2.948e-07
254 MUSCLE CELL DIFFERENTIATION 85 237 1.631e-08 2.988e-07
255 REGULATION OF MAP KINASE ACTIVITY 107 319 1.671e-08 3.042e-07
256 POSITIVE REGULATION OF LIPASE ACTIVITY 34 66 1.674e-08 3.042e-07
257 NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH 40 84 1.737e-08 3.145e-07
258 ARTERY DEVELOPMENT 37 75 1.799e-08 3.245e-07
259 POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION 46 103 1.908e-08 3.427e-07
260 PHOSPHATE CONTAINING COMPOUND METABOLIC PROCESS 497 1977 1.939e-08 3.471e-07
261 REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL 30 55 2.078e-08 3.705e-07
262 ACTION POTENTIAL 43 94 2.304e-08 4.092e-07
263 RESPONSE TO KETONE 69 182 2.909e-08 5.146e-07
264 REGULATION OF CELLULAR RESPONSE TO STRESS 199 691 3.515e-08 6.196e-07
265 RESPIRATORY SYSTEM DEVELOPMENT 73 197 3.545e-08 6.225e-07
266 POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT 30 56 3.609e-08 6.289e-07
267 NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 94 274 3.604e-08 6.289e-07
268 REGULATION OF NEUROTRANSMITTER LEVELS 71 190 3.662e-08 6.359e-07
269 REGULATION OF HEART RATE 40 86 3.975e-08 6.858e-07
270 MUSCLE SYSTEM PROCESS 96 282 3.979e-08 6.858e-07
271 NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION 32 62 4.141e-08 7.084e-07
272 POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING 32 62 4.141e-08 7.084e-07
273 CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND 143 465 4.38e-08 7.465e-07
274 CARDIAC MUSCLE CELL DIFFERENTIATION 36 74 4.438e-08 7.536e-07
275 REGULATION OF TRANSPORTER ACTIVITY 73 198 4.511e-08 7.633e-07
276 ACTIVATION OF PROTEIN KINASE ACTIVITY 95 279 4.616e-08 7.782e-07
277 CARDIOCYTE DIFFERENTIATION 43 96 4.936e-08 8.292e-07
278 PALLIUM DEVELOPMENT 60 153 5.561e-08 9.308e-07
279 SECOND MESSENGER MEDIATED SIGNALING 62 160 5.657e-08 9.434e-07
280 RESPONSE TO DRUG 134 431 5.685e-08 9.448e-07
281 CELL JUNCTION ORGANIZATION 69 185 6.18e-08 1.023e-06
282 METANEPHROS DEVELOPMENT 38 81 6.482e-08 1.07e-06
283 MULTICELLULAR ORGANISMAL SIGNALING 51 123 6.653e-08 1.094e-06
284 OSSIFICATION 87 251 6.763e-08 1.108e-06
285 EMBRYONIC CRANIAL SKELETON MORPHOGENESIS 26 46 6.87e-08 1.122e-06
286 ENDOTHELIAL CELL DIFFERENTIATION 35 72 6.977e-08 1.135e-06
287 SYNAPSE ASSEMBLY 34 69 7.004e-08 1.135e-06
288 GLAND MORPHOGENESIS 43 97 7.136e-08 1.149e-06
289 EXTRACELLULAR STRUCTURE ORGANIZATION 101 304 7.13e-08 1.149e-06
290 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION 47 110 7.202e-08 1.156e-06
291 AMEBOIDAL TYPE CELL MIGRATION 60 154 7.323e-08 1.171e-06
292 RESPONSE TO BMP 42 94 7.673e-08 1.219e-06
293 CELLULAR RESPONSE TO BMP STIMULUS 42 94 7.673e-08 1.219e-06
294 REGULATION OF STEM CELL PROLIFERATION 40 88 8.741e-08 1.383e-06
295 WOUND HEALING 143 470 9.039e-08 1.422e-06
296 NEGATIVE REGULATION OF TRANSPORT 140 458 9.047e-08 1.422e-06
297 CALCIUM ION TRANSPORT 79 223 9.405e-08 1.473e-06
298 CRANIAL SKELETAL SYSTEM DEVELOPMENT 29 55 9.655e-08 1.508e-06
299 BONE MORPHOGENESIS 37 79 1.016e-07 1.58e-06
300 REGULATION OF ENDOTHELIAL CELL PROLIFERATION 43 98 1.023e-07 1.587e-06
301 RESPONSE TO INORGANIC SUBSTANCE 145 479 1.037e-07 1.604e-06
302 POSITIVE REGULATION OF DENDRITE DEVELOPMENT 32 64 1.093e-07 1.684e-06
303 REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION 68 184 1.157e-07 1.776e-06
304 CELL GROWTH 54 135 1.168e-07 1.788e-06
305 NEGATIVE REGULATION OF CELL DEVELOPMENT 100 303 1.191e-07 1.816e-06
306 REGIONALIZATION 102 311 1.264e-07 1.922e-06
307 LOCOMOTORY BEHAVIOR 67 181 1.33e-07 2.016e-06
308 REGULATION OF PHOSPHOLIPASE C ACTIVITY 23 39 1.35e-07 2.04e-06
309 REGULATION OF OSTEOBLAST DIFFERENTIATION 47 112 1.393e-07 2.098e-06
310 HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 59 153 1.431e-07 2.148e-06
311 REGULATION OF ACTIN FILAMENT BASED PROCESS 102 312 1.508e-07 2.257e-06
312 NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION 28 53 1.518e-07 2.264e-06
313 CELL MATRIX ADHESION 49 119 1.545e-07 2.297e-06
314 NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS 289 1087 1.57e-07 2.326e-06
315 SECRETION 171 588 1.596e-07 2.35e-06
316 REGULATION OF BMP SIGNALING PATHWAY 36 77 1.591e-07 2.35e-06
317 SMAD PROTEIN SIGNAL TRANSDUCTION 29 56 1.615e-07 2.363e-06
318 REGULATION OF DENDRITIC SPINE DEVELOPMENT 29 56 1.615e-07 2.363e-06
319 ION HOMEOSTASIS 168 576 1.661e-07 2.422e-06
320 ORGAN GROWTH 33 68 1.726e-07 2.509e-06
321 REGULATION OF CELLULAR PROTEIN LOCALIZATION 162 552 1.786e-07 2.589e-06
322 CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES 73 204 1.805e-07 2.608e-06
323 CARDIAC MUSCLE TISSUE DEVELOPMENT 55 140 1.824e-07 2.627e-06
324 REGULATION OF MUSCLE TISSUE DEVELOPMENT 44 103 1.873e-07 2.69e-06
325 REGULATION OF SYNAPSE ORGANIZATION 47 113 1.919e-07 2.739e-06
326 REGULATION OF STEM CELL DIFFERENTIATION 47 113 1.919e-07 2.739e-06
327 RESPONSE TO TRANSFORMING GROWTH FACTOR BETA 56 144 2.114e-07 3.009e-06
328 POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 26 48 2.185e-07 3.1e-06
329 NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION 48 117 2.351e-07 3.325e-06
330 ARTERY MORPHOGENESIS 27 51 2.388e-07 3.357e-06
331 NEGATIVE REGULATION OF CHEMOTAXIS 27 51 2.388e-07 3.357e-06
332 REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 35 75 2.493e-07 3.494e-06
333 INOSITOL LIPID MEDIATED SIGNALING 50 124 2.525e-07 3.528e-06
334 STRIATED MUSCLE CELL DIFFERENTIATION 64 173 2.578e-07 3.581e-06
335 SIGNAL RELEASE 64 173 2.578e-07 3.581e-06
336 REGULATION OF EMBRYONIC DEVELOPMENT 47 114 2.627e-07 3.638e-06
337 SECRETION BY CELL 145 486 2.711e-07 3.735e-06
338 REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 30 60 2.713e-07 3.735e-06
339 POSITIVE REGULATION OF CELL DEATH 174 605 2.798e-07 3.84e-06
340 CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS 68 188 2.96e-07 4.049e-06
341 CELL PROLIFERATION 190 672 2.967e-07 4.049e-06
342 PALATE DEVELOPMENT 38 85 3.094e-07 4.21e-06
343 MEMORY 42 98 3.168e-07 4.297e-06
344 ORGANIC ANION TRANSPORT 120 387 3.226e-07 4.364e-06
345 KIDNEY MORPHOGENESIS 37 82 3.311e-07 4.466e-06
346 CYCLIC NUCLEOTIDE MEDIATED SIGNALING 25 46 3.428e-07 4.597e-06
347 RESPONSE TO ESTROGEN 76 218 3.42e-07 4.597e-06
348 POSITIVE REGULATION OF MAP KINASE ACTIVITY 73 207 3.478e-07 4.651e-06
349 REPRODUCTIVE SYSTEM DEVELOPMENT 125 408 3.807e-07 5.061e-06
350 SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION 124 404 3.8e-07 5.061e-06
351 POSITIVE REGULATION OF POTASSIUM ION TRANSPORT 22 38 3.973e-07 5.267e-06
352 POST EMBRYONIC DEVELOPMENT 39 89 4.123e-07 5.45e-06
353 DIVALENT INORGANIC CATION TRANSPORT 89 268 4.253e-07 5.606e-06
354 REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 70 197 4.338e-07 5.702e-06
355 REGULATION OF SYNAPTIC PLASTICITY 54 140 4.705e-07 6.15e-06
356 CELL FATE COMMITMENT 78 227 4.704e-07 6.15e-06
357 ORGANIC ACID TRANSPORT 87 261 4.763e-07 6.208e-06
358 REGULATION OF CELL SIZE 63 172 4.787e-07 6.222e-06
359 POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS 124 406 5.083e-07 6.588e-06
360 NEGATIVE REGULATION OF KINASE ACTIVITY 84 250 5.117e-07 6.613e-06
361 NEPHRON EPITHELIUM DEVELOPMENT 40 93 5.356e-07 6.903e-06
362 DEVELOPMENTAL CELL GROWTH 35 77 5.5e-07 7.07e-06
363 REGULATION OF MUSCLE ORGAN DEVELOPMENT 43 103 5.54e-07 7.102e-06
364 REGULATION OF HORMONE SECRETION 87 262 5.728e-07 7.322e-06
365 NEGATIVE REGULATION OF NEURON DIFFERENTIATION 68 191 5.804e-07 7.398e-06
366 REGULATION OF CELL MATRIX ADHESION 39 90 5.859e-07 7.449e-06
367 POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 94 289 5.894e-07 7.473e-06
368 NEUROTRANSMITTER TRANSPORT 58 155 5.94e-07 7.51e-06
369 OUTFLOW TRACT MORPHOGENESIS 28 56 6.746e-07 8.507e-06
370 POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT 51 131 6.955e-07 8.746e-06
371 REGULATION OF ENDOTHELIAL CELL MIGRATION 46 114 7.326e-07 9.188e-06
372 NEGATIVE CHEMOTAXIS 22 39 7.368e-07 9.216e-06
373 RESPONSE TO EXTRACELLULAR STIMULUS 132 441 7.562e-07 9.433e-06
374 CARDIAC CHAMBER MORPHOGENESIS 43 104 7.604e-07 9.46e-06
375 REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 117 381 7.79e-07 9.666e-06
376 RENAL TUBULE DEVELOPMENT 35 78 8.04e-07 9.949e-06
377 CELLULAR RESPONSE TO EXTERNAL STIMULUS 87 264 8.237e-07 1.017e-05
378 ANION TRANSPORT 148 507 8.45e-07 1.04e-05
379 REGULATION OF EXTENT OF CELL GROWTH 42 101 8.473e-07 1.04e-05
380 IMMUNE SYSTEM DEVELOPMENT 166 582 9.209e-07 1.128e-05
381 EXOCRINE SYSTEM DEVELOPMENT 24 45 9.309e-07 1.137e-05
382 REGULATION OF MESENCHYMAL CELL PROLIFERATION 20 34 9.473e-07 1.154e-05
383 MESODERM MORPHOGENESIS 31 66 1.002e-06 1.217e-05
384 NEURAL CREST CELL MIGRATION 26 51 1.041e-06 1.254e-05
385 CEREBRAL CORTEX DEVELOPMENT 43 105 1.037e-06 1.254e-05
386 CELL JUNCTION ASSEMBLY 50 129 1.039e-06 1.254e-05
387 CARDIAC MUSCLE CELL ACTION POTENTIAL 21 37 1.148e-06 1.377e-05
388 AXON EXTENSION 21 37 1.148e-06 1.377e-05
389 POSITIVE REGULATION OF VASCULATURE DEVELOPMENT 51 133 1.19e-06 1.423e-05
390 MULTI MULTICELLULAR ORGANISM PROCESS 73 213 1.206e-06 1.439e-05
391 ENDOCRINE SYSTEM DEVELOPMENT 48 123 1.346e-06 1.602e-05
392 OVULATION CYCLE 45 113 1.483e-06 1.76e-05
393 POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION 31 67 1.504e-06 1.776e-05
394 REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 31 67 1.504e-06 1.776e-05
395 MUSCLE CONTRACTION 78 233 1.509e-06 1.778e-05
396 CALCIUM ION TRANSMEMBRANE TRANSPORT 58 159 1.559e-06 1.832e-05
397 REGULATION OF NEURON APOPTOTIC PROCESS 67 192 1.586e-06 1.859e-05
398 NEGATIVE REGULATION OF CELL GROWTH 61 170 1.603e-06 1.874e-05
399 EMBRYONIC PATTERN SPECIFICATION 28 58 1.669e-06 1.947e-05
400 FORMATION OF PRIMARY GERM LAYER 44 110 1.675e-06 1.949e-05
401 REGULATION OF DENDRITE MORPHOGENESIS 33 74 1.95e-06 2.263e-05
402 NEGATIVE REGULATION OF CELL MATRIX ADHESION 18 30 2.237e-06 2.583e-05
403 REGULATION OF DENDRITIC SPINE MORPHOGENESIS 18 30 2.237e-06 2.583e-05
404 METAL ION TRANSPORT 164 582 2.367e-06 2.726e-05
405 CAMERA TYPE EYE MORPHOGENESIS 41 101 2.395e-06 2.752e-05
406 EYE MORPHOGENESIS 51 136 2.572e-06 2.948e-05
407 POSITIVE REGULATION OF INTRACELLULAR TRANSPORT 112 370 2.838e-06 3.245e-05
408 SMOOTH MUSCLE TISSUE DEVELOPMENT 13 18 2.943e-06 3.356e-05
409 IN UTERO EMBRYONIC DEVELOPMENT 97 311 3.168e-06 3.604e-05
410 RESPONSE TO PEPTIDE 120 404 3.58e-06 4.063e-05
411 CRANIAL NERVE MORPHOGENESIS 15 23 3.642e-06 4.113e-05
412 COCHLEA DEVELOPMENT 21 39 3.639e-06 4.113e-05
413 ERBB SIGNALING PATHWAY 34 79 3.656e-06 4.119e-05
414 ORGANIC HYDROXY COMPOUND METABOLIC PROCESS 139 482 3.686e-06 4.143e-05
415 SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION 107 352 3.796e-06 4.256e-05
416 CARDIAC VENTRICLE DEVELOPMENT 42 106 3.813e-06 4.264e-05
417 AUTONOMIC NERVOUS SYSTEM DEVELOPMENT 22 42 3.921e-06 4.375e-05
418 SPROUTING ANGIOGENESIS 23 45 4.104e-06 4.569e-05
419 DIGESTIVE TRACT MORPHOGENESIS 24 48 4.196e-06 4.659e-05
420 NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT 84 262 4.328e-06 4.794e-05
421 SINGLE ORGANISM CELL ADHESION 133 459 4.541e-06 5.017e-05
422 CELLULAR RESPONSE TO PEPTIDE 87 274 4.55e-06 5.017e-05
423 REGULATION OF POTASSIUM ION TRANSPORT 35 83 4.637e-06 5.1e-05
424 CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT 31 70 4.726e-06 5.187e-05
425 LIMBIC SYSTEM DEVELOPMENT 40 100 4.88e-06 5.343e-05
426 REGULATION OF WNT SIGNALING PATHWAY 96 310 4.971e-06 5.407e-05
427 REGULATION OF CALCIUM ION TRANSPORT 70 209 4.974e-06 5.407e-05
428 TRANSMEMBRANE TRANSPORT 282 1098 4.96e-06 5.407e-05
429 NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT 34 80 5.127e-06 5.56e-05
430 EMBRYONIC CAMERA TYPE EYE FORMATION 10 12 5.14e-06 5.562e-05
431 NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT 16 26 5.208e-06 5.623e-05
432 LIPID TRANSLOCATION 14 21 5.3e-06 5.708e-05
433 REGULATION OF CYTOSKELETON ORGANIZATION 143 502 5.527e-06 5.94e-05
434 POSITIVE REGULATION OF STEM CELL PROLIFERATION 28 61 5.791e-06 6.209e-05
435 FORELIMB MORPHOGENESIS 21 40 6.198e-06 6.63e-05
436 CELLULAR CHEMICAL HOMEOSTASIS 159 570 6.279e-06 6.7e-05
437 CELLULAR HOMEOSTASIS 184 676 6.414e-06 6.83e-05
438 POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS 92 296 6.572e-06 6.981e-05
439 REGULATION OF EPITHELIAL CELL DIFFERENTIATION 46 122 6.593e-06 6.988e-05
440 POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION 108 360 6.616e-06 6.997e-05
441 REGULATION OF SMOOTH MUSCLE CELL MIGRATION 24 49 6.646e-06 6.997e-05
442 PROTEIN LOCALIZATION 439 1805 6.639e-06 6.997e-05
443 NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION 44 115 6.683e-06 7.009e-05
444 CARDIAC MUSCLE CELL CONTRACTION 17 29 6.703e-06 7.009e-05
445 POSITIVE REGULATION OF CARTILAGE DEVELOPMENT 17 29 6.703e-06 7.009e-05
446 POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 30 68 7.354e-06 7.672e-05
447 NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION 52 144 7.39e-06 7.693e-05
448 POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 13 19 7.579e-06 7.861e-05
449 ODONTOGENESIS 41 105 7.585e-06 7.861e-05
450 GLYCOPROTEIN METABOLIC PROCESS 106 353 7.659e-06 7.919e-05
451 REGULATION OF CELLULAR COMPONENT SIZE 102 337 7.762e-06 8.008e-05
452 NEGATIVE REGULATION OF SECRETION 67 200 7.783e-06 8.012e-05
453 OVULATION CYCLE PROCESS 36 88 7.841e-06 8.054e-05
454 EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS 15 24 7.884e-06 8.08e-05
455 NEGATIVE REGULATION OF CELL ADHESION 73 223 7.921e-06 8.1e-05
456 SALIVARY GLAND DEVELOPMENT 18 32 8.005e-06 8.16e-05
457 REGULATION OF JNK CASCADE 56 159 8.014e-06 8.16e-05
458 DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION 166 602 8.152e-06 8.282e-05
459 SEX DIFFERENTIATION 84 266 8.318e-06 8.432e-05
460 FOREBRAIN CELL MIGRATION 28 62 8.525e-06 8.605e-05
461 CARDIAC VENTRICLE MORPHOGENESIS 28 62 8.525e-06 8.605e-05
462 NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY 40 102 8.628e-06 8.69e-05
463 REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION 42 109 8.73e-06 8.773e-05
464 HEART PROCESS 35 85 8.783e-06 8.807e-05
465 VASCULOGENESIS 27 59 9.079e-06 9.085e-05
466 NEGATIVE REGULATION OF MAPK CASCADE 52 145 9.272e-06 9.259e-05
467 NEGATIVE REGULATION OF NEURON DEATH 59 171 9.634e-06 9.599e-05
468 COLLAGEN FIBRIL ORGANIZATION 20 38 9.803e-06 9.674e-05
469 POSITIVE REGULATION OF BIOMINERAL TISSUE DEVELOPMENT 20 38 9.803e-06 9.674e-05
470 MESENCHYME MORPHOGENESIS 20 38 9.803e-06 9.674e-05
471 POSITIVE REGULATION OF CHEMOTAXIS 45 120 9.744e-06 9.674e-05
472 CARDIAC CONDUCTION 34 82 9.814e-06 9.674e-05
473 NEURON PROJECTION EXTENSION 25 53 1.001e-05 9.827e-05
474 CYTOSOLIC CALCIUM ION TRANSPORT 25 53 1.001e-05 9.827e-05
475 DIVALENT INORGANIC CATION HOMEOSTASIS 103 343 1.022e-05 0.0001001
476 NEGATIVE REGULATION OF AXON GUIDANCE 16 27 1.037e-05 0.0001012
477 POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 16 27 1.037e-05 0.0001012
478 ANTERIOR POSTERIOR PATTERN SPECIFICATION 65 194 1.049e-05 0.000102
479 POSITIVE REGULATION OF AXONOGENESIS 30 69 1.05e-05 0.000102
480 EPITHELIAL CELL PROLIFERATION 36 89 1.061e-05 0.0001029
481 REGULATION OF NEURON DEATH 80 252 1.087e-05 0.0001051
482 DENDRITE DEVELOPMENT 33 79 1.094e-05 0.0001056
483 REGULATION OF RESPONSE TO WOUNDING 120 413 1.132e-05 0.000109
484 NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS 49 135 1.139e-05 0.0001095
485 RESPONSE TO ESTRADIOL 52 146 1.159e-05 0.0001112
486 RESPONSE TO CORTICOSTEROID 60 176 1.24e-05 0.0001188
487 NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS 45 121 1.249e-05 0.0001193
488 POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION 17 30 1.254e-05 0.0001193
489 REGULATION OF HEART RATE BY CARDIAC CONDUCTION 17 30 1.254e-05 0.0001193
490 REGULATION OF MUSCLE SYSTEM PROCESS 65 195 1.266e-05 0.0001202
491 REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 39 100 1.295e-05 0.0001227
492 REGULATION OF SEQUESTERING OF CALCIUM ION 41 107 1.302e-05 0.0001231
493 REGULATION OF SMOOTH MUSCLE CONTRACTION 27 60 1.333e-05 0.0001253
494 POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION 27 60 1.333e-05 0.0001253
495 POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION 27 60 1.333e-05 0.0001253
496 REGULATION OF ORGAN GROWTH 31 73 1.345e-05 0.0001262
497 REGULATION OF ORGANELLE ORGANIZATION 297 1178 1.359e-05 0.0001273
498 AXIS SPECIFICATION 36 90 1.426e-05 0.0001331
499 EMBRYONIC EYE MORPHOGENESIS 18 33 1.427e-05 0.0001331
500 SKIN DEVELOPMENT 69 211 1.438e-05 0.0001336
501 MESODERM DEVELOPMENT 44 118 1.437e-05 0.0001336
502 POSITIVE REGULATION OF CATION TRANSMEMBRANE TRANSPORT 38 97 1.474e-05 0.0001366
503 EPITHELIAL CELL MORPHOGENESIS 21 42 1.664e-05 0.0001536
504 ENDOCHONDRAL BONE MORPHOGENESIS 22 45 1.663e-05 0.0001536
505 REGULATION OF RESPONSE TO STRESS 361 1468 1.724e-05 0.0001588
506 REGULATION OF NEUROTRANSMITTER TRANSPORT 28 64 1.779e-05 0.0001636
507 ACTIN FILAMENT BASED PROCESS 128 450 1.811e-05 0.0001662
508 EYELID DEVELOPMENT IN CAMERA TYPE EYE 10 13 1.819e-05 0.0001666
509 VASCULAR PROCESS IN CIRCULATORY SYSTEM 56 163 1.844e-05 0.0001686
510 REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT 27 61 1.932e-05 0.0001763
511 SKIN EPIDERMIS DEVELOPMENT 30 71 2.073e-05 0.0001884
512 DICARBOXYLIC ACID TRANSPORT 30 71 2.073e-05 0.0001884
513 FEMALE SEX DIFFERENTIATION 43 116 2.116e-05 0.0001915
514 PRESYNAPTIC PROCESS INVOLVED IN SYNAPTIC TRANSMISSION 43 116 2.116e-05 0.0001915
515 GLIOGENESIS 59 175 2.127e-05 0.0001922
516 RENAL SYSTEM PROCESS 39 102 2.218e-05 2e-04
517 REGULATION OF PROTEIN IMPORT 61 183 2.303e-05 0.0002072
518 EPIDERMIS DEVELOPMENT 79 253 2.376e-05 0.0002134
519 RESPONSE TO FLUID SHEAR STRESS 18 34 2.458e-05 0.0002189
520 RESPONSE TO AUDITORY STIMULUS 14 23 2.46e-05 0.0002189
521 REGULATION OF METANEPHROS DEVELOPMENT 14 23 2.46e-05 0.0002189
522 CAMP METABOLIC PROCESS 18 34 2.458e-05 0.0002189
523 INNERVATION 14 23 2.46e-05 0.0002189
524 RESPONSE TO REACTIVE OXYGEN SPECIES 63 191 2.465e-05 0.0002189
525 REGULATION OF FAT CELL DIFFERENTIATION 40 106 2.507e-05 0.0002218
526 CYTOSKELETON ORGANIZATION 218 838 2.506e-05 0.0002218
527 CELLULAR RESPONSE TO RETINOIC ACID 28 65 2.524e-05 0.0002228
528 REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 38 99 2.539e-05 0.0002233
529 REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 38 99 2.539e-05 0.0002233
530 REGULATION OF MEMBRANE LIPID DISTRIBUTION 19 37 2.584e-05 0.0002264
531 CAMP MEDIATED SIGNALING 19 37 2.584e-05 0.0002264
532 CRANIAL NERVE DEVELOPMENT 21 43 2.633e-05 0.0002303
533 REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION 66 203 2.682e-05 0.0002342
534 MUSCLE CELL DEVELOPMENT 46 128 2.784e-05 0.0002426
535 ION TRANSMEMBRANE TRANSPORT 214 822 2.821e-05 0.0002454
536 REGULATION OF BLOOD PRESSURE 57 169 2.87e-05 0.0002491
537 WNT SIGNALING PATHWAY 103 351 2.949e-05 0.0002555
538 CELLULAR RESPONSE TO OXYGEN LEVELS 50 143 2.979e-05 0.0002576
539 REPRODUCTION 321 1297 3.021e-05 0.0002608
540 REGULATION OF MUSCLE CONTRACTION 51 147 3.166e-05 0.0002728
541 STEROID HORMONE MEDIATED SIGNALING PATHWAY 45 125 3.221e-05 0.000277
542 RESPONSE TO RETINOIC ACID 40 107 3.227e-05 0.000277
543 CELLULAR RESPONSE TO STRESS 380 1565 3.377e-05 0.0002893
544 REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 70 220 3.442e-05 0.0002944
545 REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE 24 53 3.5e-05 0.0002983
546 MESONEPHRIC TUBULE MORPHOGENESIS 24 53 3.5e-05 0.0002983
547 GASTRULATION 53 155 3.529e-05 0.0002996
548 DEVELOPMENTAL MATURATION 63 193 3.525e-05 0.0002996
549 REGULATION OF VASOCONSTRICTION 28 66 3.54e-05 0.0003001
550 POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 16 29 3.556e-05 0.0003009
551 REGULATION OF CANONICAL WNT SIGNALING PATHWAY 74 236 3.623e-05 0.0003059
552 RESPONSE TO FATTY ACID 33 83 3.696e-05 0.0003115
553 NEURON CELL CELL ADHESION 11 16 3.719e-05 0.0003123
554 RESPONSE TO PROGESTERONE 23 50 3.725e-05 0.0003123
555 RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE 11 16 3.719e-05 0.0003123
556 CHONDROCYTE DEVELOPMENT 13 21 3.763e-05 0.0003143
557 SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT 13 21 3.763e-05 0.0003143
558 LIPID LOCALIZATION 81 264 3.778e-05 0.000315
559 EMBRYONIC FORELIMB MORPHOGENESIS 17 32 3.898e-05 0.0003245
560 PEPTIDYL TYROSINE MODIFICATION 61 186 3.981e-05 0.0003308
561 REGULATION OF WOUND HEALING 45 126 4.036e-05 0.0003348
562 POSITIVE REGULATION OF SECRETION 107 370 4.077e-05 0.0003376
563 REGULATION OF MUSCLE CELL DIFFERENTIATION 52 152 4.099e-05 0.0003379
564 POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT 18 35 4.103e-05 0.0003379
565 RESPONSE TO IRON ION 18 35 4.103e-05 0.0003379
566 STEM CELL PROLIFERATION 26 60 4.295e-05 0.0003531
567 CYCLIC NUCLEOTIDE METABOLIC PROCESS 25 57 4.694e-05 0.0003852
568 CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS 14 24 4.801e-05 0.0003926
569 REGULATION OF ODONTOGENESIS 14 24 4.801e-05 0.0003926
570 POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 141 514 4.994e-05 0.0004077
571 POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT 85 282 5.019e-05 0.000409
572 INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 10 14 5.201e-05 0.0004224
573 REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY 10 14 5.201e-05 0.0004224
574 REGULATION OF NEUROTRANSMITTER SECRETION 23 51 5.49e-05 0.0004442
575 CELLULAR RESPONSE TO FATTY ACID 23 51 5.49e-05 0.0004442
576 CELLULAR RESPONSE TO INSULIN STIMULUS 50 146 5.529e-05 0.0004467
577 REGULATION OF PROTEIN TARGETING 91 307 5.554e-05 0.0004479
578 ACTIVATION OF PHOSPHOLIPASE C ACTIVITY 15 27 5.617e-05 0.0004506
579 EXCITATORY POSTSYNAPTIC POTENTIAL 15 27 5.617e-05 0.0004506
580 CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS 15 27 5.617e-05 0.0004506
581 REGULATION OF COAGULATION 34 88 5.672e-05 0.0004535
582 REGULATION OF CATION CHANNEL ACTIVITY 34 88 5.672e-05 0.0004535
583 REGULATION OF BINDING 85 283 5.766e-05 0.0004602
584 CATION TRANSPORT 206 796 5.799e-05 0.0004612
585 PROTEIN AUTOPHOSPHORYLATION 62 192 5.793e-05 0.0004612
586 AMINO ACID TRANSPORT 44 124 5.837e-05 0.0004635
587 EMBRYONIC DIGIT MORPHOGENESIS 26 61 6.051e-05 0.0004797
588 MEMBRANE BIOGENESIS 16 30 6.187e-05 0.0004879
589 SMOOTH MUSCLE CELL DIFFERENTIATION 16 30 6.187e-05 0.0004879
590 MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 16 30 6.187e-05 0.0004879
591 MAMMARY GLAND DEVELOPMENT 42 117 6.266e-05 0.0004925
592 POSITIVE REGULATION OF LIPID METABOLIC PROCESS 45 128 6.256e-05 0.0004925
593 LIPID PHOSPHORYLATION 37 99 6.312e-05 0.0004953
594 HORMONE MEDIATED SIGNALING PATHWAY 53 158 6.334e-05 0.0004961
595 NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION 180 684 6.425e-05 0.0005024
596 CATECHOLAMINE METABOLIC PROCESS 20 42 6.453e-05 0.0005026
597 REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL 35 92 6.459e-05 0.0005026
598 CATECHOL CONTAINING COMPOUND METABOLIC PROCESS 20 42 6.453e-05 0.0005026
599 CARDIAC SEPTUM DEVELOPMENT 33 85 6.48e-05 0.0005033
600 NEURON RECOGNITION 17 33 6.523e-05 0.000505
601 NEGATIVE REGULATION OF JNK CASCADE 17 33 6.523e-05 0.000505
602 REGULATION OF AXON GUIDANCE 19 39 6.619e-05 0.0005099
603 ANATOMICAL STRUCTURE MATURATION 19 39 6.619e-05 0.0005099
604 GLANDULAR EPITHELIAL CELL DIFFERENTIATION 19 39 6.619e-05 0.0005099
605 REGULATION OF VESICLE MEDIATED TRANSPORT 128 462 6.755e-05 0.0005194
606 POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT 43 121 6.765e-05 0.0005194
607 MECHANOSENSORY BEHAVIOR 9 12 6.957e-05 0.0005333
608 REGULATION OF CALCIUM ION IMPORT 38 103 7.005e-05 0.0005361
609 REGULATION OF PEPTIDE SECRETION 66 209 7.323e-05 0.0005595
610 CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS 13 22 7.487e-05 0.0005702
611 ACTIVIN RECEPTOR SIGNALING PATHWAY 13 22 7.487e-05 0.0005702
612 CALCIUM ION IMPORT 27 65 7.552e-05 0.0005733
613 NEGATIVE REGULATION OF AXONOGENESIS 27 65 7.552e-05 0.0005733
614 REGULATION OF AMINE TRANSPORT 29 72 8.129e-05 0.000616
615 PEPTIDYL SERINE MODIFICATION 50 148 8.206e-05 0.0006209
616 COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION 40 111 8.398e-05 0.0006344
617 REGULATION OF SYNAPSE ASSEMBLY 31 79 8.426e-05 0.0006354
618 LIPID MODIFICATION 66 210 8.591e-05 0.0006468
619 CARDIAC CELL DEVELOPMENT 22 49 8.611e-05 0.0006473
620 CELLULAR RESPONSE TO STEROID HORMONE STIMULUS 68 218 8.755e-05 0.000656
621 REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 68 218 8.755e-05 0.000656
622 STARTLE RESPONSE 14 25 8.874e-05 0.0006638
623 NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY 44 126 8.986e-05 0.0006712
624 PERIPHERAL NERVOUS SYSTEM DEVELOPMENT 28 69 9.175e-05 0.0006842
625 PEPTIDYL THREONINE MODIFICATION 21 46 9.224e-05 0.0006867
626 CELLULAR LIPID METABOLIC PROCESS 231 913 9.787e-05 0.0007275
627 HINDLIMB MORPHOGENESIS 18 37 0.0001051 0.0007801
628 HEART VALVE DEVELOPMENT 17 34 0.0001059 0.0007845
629 POSITIVE REGULATION OF BINDING 44 127 0.0001108 0.0008197
630 RESPONSE TO METAL ION 96 333 0.0001118 0.000826
631 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT 41 116 0.0001133 0.0008356
632 AXONAL FASCICULATION 12 20 0.0001165 0.0008561
633 NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION 12 20 0.0001165 0.0008561
634 RETINA DEVELOPMENT IN CAMERA TYPE EYE 45 131 0.0001171 0.0008593
635 AGING 79 264 0.000118 0.0008644
636 DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS 67 216 0.0001183 0.0008653
637 REGULATED EXOCYTOSIS 69 224 0.0001194 0.0008723
638 RESPONSE TO HYDROGEN PEROXIDE 39 109 0.0001221 0.0008902
639 SYSTEM PROCESS 423 1785 0.000123 0.0008955
640 REGULATION OF ORGANIC ACID TRANSPORT 22 50 0.0001245 0.0009022
641 POSITIVE REGULATION OF STEM CELL DIFFERENTIATION 22 50 0.0001245 0.0009022
642 RESPONSE TO STARVATION 51 154 0.0001244 0.0009022
643 BLASTODERM SEGMENTATION 10 15 0.0001275 0.0009229
644 RESPONSE TO PURINE CONTAINING COMPOUND 52 158 0.0001285 0.0009283
645 REGULATION OF CELL SHAPE 47 139 0.0001289 0.0009301
646 CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION 54 166 0.0001358 0.0009782
647 TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 35 95 0.0001372 0.0009869
648 REGULATION OF CELL CYCLE 238 949 0.0001383 0.0009933
649 CELLULAR RESPONSE TO STARVATION 41 117 0.0001406 0.001008
650 CELL CELL JUNCTION ASSEMBLY 29 74 0.0001448 0.001036
651 BRANCHING INVOLVED IN URETERIC BUD MORPHOGENESIS 20 44 0.0001452 0.001038
652 SENSORY PERCEPTION OF MECHANICAL STIMULUS 51 155 0.0001494 0.001066
653 REGULATION OF MEMBRANE DEPOLARIZATION 19 41 0.0001544 0.001092
654 AORTA DEVELOPMENT 19 41 0.0001544 0.001092
655 NEGATIVE REGULATION OF STRESS ACTIVATED MAPK CASCADE 19 41 0.0001544 0.001092
656 NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 19 41 0.0001544 0.001092
657 PROSTATE GLAND DEVELOPMENT 19 41 0.0001544 0.001092
658 LUNG ALVEOLUS DEVELOPMENT 19 41 0.0001544 0.001092
659 REPLACEMENT OSSIFICATION 14 26 0.0001564 0.001099
660 RESPONSE TO CORTICOSTERONE 14 26 0.0001564 0.001099
661 REGULATION OF AMINO ACID TRANSPORT 14 26 0.0001564 0.001099
662 ENDOCHONDRAL OSSIFICATION 14 26 0.0001564 0.001099
663 REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 15 29 0.0001656 0.00116
664 EMBRYONIC HINDLIMB MORPHOGENESIS 15 29 0.0001656 0.00116
665 EMBRYONIC CAMERA TYPE EYE DEVELOPMENT 17 35 0.0001671 0.001169
666 ENDOCARDIAL CUSHION DEVELOPMENT 16 32 0.0001687 0.001172
667 POSITIVE REGULATION OF BMP SIGNALING PATHWAY 16 32 0.0001687 0.001172
668 BICELLULAR TIGHT JUNCTION ASSEMBLY 16 32 0.0001687 0.001172
669 METANEPHRIC NEPHRON DEVELOPMENT 16 32 0.0001687 0.001172
670 ADIPOSE TISSUE DEVELOPMENT 16 32 0.0001687 0.001172
671 GLYCOSYLATION 79 267 0.0001765 0.001224
672 POSITIVE REGULATION OF SYNAPSE ASSEMBLY 25 61 0.0001779 0.001232
673 POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC 11 18 0.0001805 0.001246
674 PERICARDIUM DEVELOPMENT 11 18 0.0001805 0.001246
675 HINDBRAIN DEVELOPMENT 46 137 0.0001819 0.001254
676 SEGMENTATION 33 89 0.0001829 0.001259
677 REGULATION OF NUCLEOTIDE METABOLIC PROCESS 65 211 0.0001844 0.001267
678 TYPE B PANCREATIC CELL DEVELOPMENT 9 13 0.0001852 0.001271
679 SENSORY PERCEPTION OF PAIN 29 75 0.0001907 0.001303
680 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL 29 75 0.0001907 0.001303
681 POSITIVE REGULATION OF AUTOPHAGY 29 75 0.0001907 0.001303
682 REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT 21 48 0.0001945 0.001325
683 RESPONSE TO AXON INJURY 21 48 0.0001945 0.001325
684 NEGATIVE REGULATION OF WOUND HEALING 24 58 0.0001997 0.001359
685 ACTIN FILAMENT BASED MOVEMENT 34 93 0.0002016 0.001369
686 POSITIVE REGULATION OF PROTEIN IMPORT 37 104 0.0002053 0.001392
687 REGULATION OF LEUKOCYTE APOPTOTIC PROCESS 30 79 0.0002169 0.001469
688 NEUROMUSCULAR PROCESS 35 97 0.0002201 0.001488
689 METANEPHRIC NEPHRON MORPHOGENESIS 12 21 0.0002216 0.001496
690 EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 23 55 0.0002234 0.001504
691 REGULATION OF KIDNEY DEVELOPMENT 23 55 0.0002234 0.001504
692 AMMONIUM ION METABOLIC PROCESS 54 169 0.0002269 0.001526
693 CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL 19 42 0.0002287 0.001529
694 DENDRITE MORPHOGENESIS 19 42 0.0002287 0.001529
695 REGULATION OF HEART GROWTH 19 42 0.0002287 0.001529
696 CALCIUM ION IMPORT INTO CYTOSOL 19 42 0.0002287 0.001529
697 RESPONSE TO OXIDATIVE STRESS 99 352 0.0002388 0.001594
698 ERBB2 SIGNALING PATHWAY 18 39 0.0002442 0.001625
699 LONG TERM SYNAPTIC POTENTIATION 18 39 0.0002442 0.001625
700 REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 65 213 0.0002478 0.001647
701 POSITIVE REGULATION OF REPRODUCTIVE PROCESS 22 52 0.0002489 0.001649
702 RESPONSE TO ACTIVITY 27 69 0.0002491 0.001649
703 ACTIVATION OF MAPKK ACTIVITY 22 52 0.0002489 0.001649
704 HEMOSTASIS 89 311 0.0002557 0.00169
705 SEMAPHORIN PLEXIN SIGNALING PATHWAY 17 36 0.0002571 0.001697
706 POSITIVE REGULATION OF HEART GROWTH 14 27 0.0002644 0.001738
707 REGULATION OF CATENIN IMPORT INTO NUCLEUS 14 27 0.0002644 0.001738
708 POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION 14 27 0.0002644 0.001738
709 POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT 76 258 0.0002689 0.001762
710 BROWN FAT CELL DIFFERENTIATION 15 30 0.0002692 0.001762
711 REGULATION OF MEMBRANE REPOLARIZATION 15 30 0.0002692 0.001762
712 GLOMERULUS DEVELOPMENT 21 49 0.0002758 0.001803
713 REGULATION OF SMAD PROTEIN IMPORT INTO NUCLEUS 10 16 0.0002781 0.00181
714 PARAXIAL MESODERM DEVELOPMENT 10 16 0.0002781 0.00181
715 STRIATUM DEVELOPMENT 10 16 0.0002781 0.00181
716 ADULT LOCOMOTORY BEHAVIOR 30 80 0.0002805 0.001823
717 POSITIVE REGULATION OF PROTEIN BINDING 28 73 0.000286 0.001854
718 HIPPOCAMPUS DEVELOPMENT 28 73 0.000286 0.001854
719 ENSHEATHMENT OF NEURONS 33 91 0.0002954 0.001909
720 AXON ENSHEATHMENT 33 91 0.0002954 0.001909
721 CELL DEATH 247 1001 0.0003012 0.001944
722 LEUKOCYTE MIGRATION 76 259 0.0003061 0.001973
723 EPITHELIAL TO MESENCHYMAL TRANSITION 23 56 0.000307 0.001976
724 CELL ACTIVATION 149 568 0.0003082 0.001978
725 GLIAL CELL DIFFERENTIATION 45 136 0.0003081 0.001978
726 MUSCLE ORGAN MORPHOGENESIS 27 70 0.000328 0.002102
727 CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS 155 595 0.0003326 0.002126
728 CEREBRAL CORTEX CELL MIGRATION 19 43 0.0003324 0.002126
729 MULTICELLULAR ORGANISMAL HOMEOSTASIS 79 272 0.0003351 0.002139
730 REGULATION OF PROTEIN SECRETION 107 389 0.0003419 0.002179
731 POSITIVE REGULATION OF CELL SUBSTRATE ADHESION 35 99 0.000345 0.002196
732 POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS 43 129 0.0003464 0.002202
733 REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY 11 19 0.0003501 0.002213
734 VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION 11 19 0.0003501 0.002213
735 NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY 11 19 0.0003501 0.002213
736 POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION 11 19 0.0003501 0.002213
737 REGULATION OF PEPTIDE TRANSPORT 75 256 0.0003519 0.002222
738 REGULATION OF CARBOHYDRATE METABOLIC PROCESS 54 172 0.0003701 0.002334
739 NEGATIVE REGULATION OF HORMONE SECRETION 28 74 0.000372 0.002342
740 CELLULAR RESPONSE TO OXIDATIVE STRESS 57 184 0.000379 0.002383
741 ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY 46 141 0.0003803 0.002388
742 REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT 21 50 0.0003854 0.002414
743 FACE DEVELOPMENT 21 50 0.0003854 0.002414
744 MYELOID LEUKOCYTE DIFFERENTIATION 34 96 0.0004008 0.002507
745 POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION 16 34 0.0004085 0.002544
746 RESPONSE TO PROSTAGLANDIN 16 34 0.0004085 0.002544
747 BRAIN MORPHOGENESIS 16 34 0.0004085 0.002544
748 REGULATION OF LIPID METABOLIC PROCESS 81 282 0.0004157 0.002586
749 POSITIVE REGULATION OF METANEPHROS DEVELOPMENT 9 14 0.0004249 0.002615
750 VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY 9 14 0.0004249 0.002615
751 MEMBRANE ASSEMBLY 13 25 0.000423 0.002615
752 REGULATION OF GLOMERULUS DEVELOPMENT 9 14 0.0004249 0.002615
753 POSITIVE REGULATION OF FATTY ACID OXIDATION 9 14 0.0004249 0.002615
754 SINGLE ORGANISM CATABOLIC PROCESS 236 957 0.0004226 0.002615
755 RESPONSE TO LAMINAR FLUID SHEAR STRESS 9 14 0.0004249 0.002615
756 REGULATION OF SYNAPTIC VESICLE TRANSPORT 15 31 0.0004243 0.002615
757 GLUTAMATE SECRETION 14 28 0.0004305 0.002629
758 REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR 14 28 0.0004305 0.002629
759 REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION 14 28 0.0004305 0.002629
760 INTERACTION WITH HOST 44 134 0.0004305 0.002629
761 REGULATION OF FATTY ACID OXIDATION 14 28 0.0004305 0.002629
762 METANEPHROS MORPHOGENESIS 14 28 0.0004305 0.002629
763 RESPONSE TO INSULIN 62 205 0.0004421 0.002694
764 MYELOID CELL DIFFERENTIATION 58 189 0.0004424 0.002694
765 CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES 36 104 0.0004551 0.002768
766 CELLULAR MACROMOLECULE LOCALIZATION 297 1234 0.0004585 0.002785
767 CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS 72 246 0.0004703 0.002853
768 VENTRICULAR SEPTUM DEVELOPMENT 22 54 0.0004713 0.002855
769 MULTI ORGANISM BEHAVIOR 28 75 0.00048 0.002905
770 NEGATIVE REGULATION OF ION TRANSPORT 42 127 0.0004859 0.002936
771 CELLULAR RESPONSE TO HYDROGEN PEROXIDE 24 61 0.0004907 0.002961
772 POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION 51 162 0.0004933 0.002973
773 RESPONSE TO AMINO ACID 38 112 0.0005039 0.003033
774 LEUKOCYTE DIFFERENTIATION 83 292 0.0005089 0.003059
775 REGULATION OF EXOCYTOSIS 57 186 0.0005122 0.003075
776 MULTICELLULAR ORGANISM REPRODUCTION 193 768 0.0005147 0.003086
777 NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION 18 41 0.0005215 0.003111
778 POSITIVE REGULATION OF KIDNEY DEVELOPMENT 18 41 0.0005215 0.003111
779 CELL SUBSTRATE JUNCTION ASSEMBLY 18 41 0.0005215 0.003111
780 GLUTAMATE RECEPTOR SIGNALING PATHWAY 18 41 0.0005215 0.003111
781 RESPONSE TO ORGANOPHOSPHORUS 45 139 0.0005276 0.003143
782 NEGATIVE REGULATION OF KIDNEY DEVELOPMENT 10 17 0.0005526 0.003267
783 BRANCH ELONGATION OF AN EPITHELIUM 10 17 0.0005526 0.003267
784 NEGATIVE REGULATION OF PLATELET ACTIVATION 10 17 0.0005526 0.003267
785 REGULATION OF ENERGY HOMEOSTASIS 10 17 0.0005526 0.003267
786 MAMMARY GLAND ALVEOLUS DEVELOPMENT 10 17 0.0005526 0.003267
787 MAMMARY GLAND LOBULE DEVELOPMENT 10 17 0.0005526 0.003267
788 NEGATIVE REGULATION OF AXON EXTENSION 17 38 0.0005679 0.003332
789 BONE MINERALIZATION 17 38 0.0005679 0.003332
790 REGULATION OF CHEMOKINE PRODUCTION 25 65 0.0005651 0.003332
791 MONOCARBOXYLIC ACID TRANSPORT 41 124 0.0005658 0.003332
792 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 17 38 0.0005679 0.003332
793 POSITIVE REGULATION OF ORGAN GROWTH 17 38 0.0005679 0.003332
794 GLYCEROLIPID METABOLIC PROCESS 98 356 0.0005748 0.003368
795 EXOCYTOSIS 87 310 0.0005912 0.00346
796 COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT 20 48 0.0005964 0.003478
797 POSITIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 20 48 0.0005964 0.003478
798 POSITIVE REGULATION OF RESPONSE TO NUTRIENT LEVELS 20 48 0.0005964 0.003478
799 POSITIVE REGULATION OF HEART CONTRACTION 16 35 0.0006117 0.003558
800 RESPONSE TO MINERALOCORTICOID 16 35 0.0006117 0.003558
801 POSITIVE REGULATION OF VACUOLE ORGANIZATION 8 12 0.0006403 0.003674
802 NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE 8 12 0.0006403 0.003674
803 REGULATION OF RECEPTOR ACTIVITY 39 117 0.0006367 0.003674
804 AXON EXTENSION INVOLVED IN AXON GUIDANCE 8 12 0.0006403 0.003674
805 REGULATION OF MESENCHYMAL CELL APOPTOTIC PROCESS 8 12 0.0006403 0.003674
806 REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY 8 12 0.0006403 0.003674
807 PARTURITION 11 20 0.0006356 0.003674
808 POSITIVE REGULATION OF CATENIN IMPORT INTO NUCLEUS 8 12 0.0006403 0.003674
809 NEGATIVE REGULATION OF OSSIFICATION 26 69 0.0006389 0.003674
810 ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 8 12 0.0006403 0.003674
811 REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY 8 12 0.0006403 0.003674
812 REGULATION OF ORGAN FORMATION 15 32 0.0006498 0.00371
813 POSITIVE REGULATION OF CELL GROWTH 47 148 0.0006487 0.00371
814 POSITIVE REGULATION OF AMINE TRANSPORT 15 32 0.0006498 0.00371
815 NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION 15 32 0.0006498 0.00371
816 LUNG MORPHOGENESIS 19 45 0.0006666 0.003801
817 ADRENAL GLAND DEVELOPMENT 12 23 0.0006785 0.003855
818 BRANCHED CHAIN AMINO ACID METABOLIC PROCESS 12 23 0.0006785 0.003855
819 REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC 14 29 0.0006777 0.003855
820 RESPONSE TO CARBOHYDRATE 52 168 0.0006806 0.003862
821 NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT 13 26 0.0006897 0.003904
822 MESODERMAL CELL DIFFERENTIATION 13 26 0.0006897 0.003904
823 CELLULAR RESPONSE TO KETONE 27 73 0.0007112 0.004021
824 POSITIVE REGULATION OF PURINE NUCLEOTIDE METABOLIC PROCESS 43 133 0.0007144 0.004029
825 POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS 43 133 0.0007144 0.004029
826 TISSUE MIGRATION 30 84 0.0007302 0.004114
827 INORGANIC ION TRANSMEMBRANE TRANSPORT 150 583 0.0007312 0.004114
828 ORGANIC ACID METABOLIC PROCESS 233 953 0.0007597 0.004269
829 NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION 62 209 0.0007684 0.004313
830 REGENERATION 50 161 0.0007849 0.004395
831 ESTABLISHMENT OF CELL POLARITY 31 88 0.0007842 0.004395
832 REGULATION OF CIRCADIAN RHYTHM 35 103 0.0007963 0.004454
833 CELLULAR RESPONSE TO CALCIUM ION 20 49 0.0008175 0.004566
834 CALCIUM ION REGULATED EXOCYTOSIS 29 81 0.0008485 0.004734
835 REGULATION OF CATABOLIC PROCESS 183 731 0.00086 0.004793
836 MESENCHYMAL TO EPITHELIAL TRANSITION 9 15 0.000871 0.00483
837 OTIC VESICLE DEVELOPMENT 9 15 0.000871 0.00483
838 CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS 9 15 0.000871 0.00483
839 REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT 9 15 0.000871 0.00483
840 PLATELET ACTIVATION 45 142 0.0008765 0.004855
841 NEUROMUSCULAR JUNCTION DEVELOPMENT 16 36 0.0008954 0.004937
842 POSITIVE REGULATION OF AXON EXTENSION 16 36 0.0008954 0.004937
843 LAMELLIPODIUM ORGANIZATION 16 36 0.0008954 0.004937
844 RESPONSE TO CALCIUM ION 38 115 0.0008943 0.004937
845 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY 27 74 0.0009061 0.004983
846 ACTIN MEDIATED CELL CONTRACTION 27 74 0.0009061 0.004983
847 INTRASPECIES INTERACTION BETWEEN ORGANISMS 19 46 0.0009219 0.005059
848 SOCIAL BEHAVIOR 19 46 0.0009219 0.005059
849 EMBRYONIC AXIS SPECIFICATION 15 33 0.0009695 0.005307
850 EMBRYONIC DIGESTIVE TRACT DEVELOPMENT 15 33 0.0009695 0.005307
851 REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY 31 89 0.0009728 0.005319
852 VESICLE MEDIATED TRANSPORT 295 1239 0.0009774 0.005338
853 CILIUM MORPHOGENESIS 61 207 0.001011 0.005517
854 ORGAN MATURATION 10 18 0.001018 0.005526
855 GLANDULAR EPITHELIAL CELL DEVELOPMENT 10 18 0.001018 0.005526
856 CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS 10 18 0.001018 0.005526
857 INOSITOL PHOSPHATE MEDIATED SIGNALING 10 18 0.001018 0.005526
858 PLASMA MEMBRANE ORGANIZATION 60 203 0.001021 0.005537
859 NEURON MATURATION 14 30 0.001035 0.005587
860 POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION 14 30 0.001035 0.005587
861 CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS 14 30 0.001035 0.005587
862 LAMELLIPODIUM ASSEMBLY 14 30 0.001035 0.005587
863 RESPONSE TO FIBROBLAST GROWTH FACTOR 38 116 0.001074 0.005789
864 AMIDE TRANSPORT 33 97 0.001082 0.005814
865 REGULATION OF CARDIAC MUSCLE CELL CONTRACTION 13 27 0.001085 0.005814
866 HIPPO SIGNALING 13 27 0.001085 0.005814
867 POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS 13 27 0.001085 0.005814
868 AXIS ELONGATION 13 27 0.001085 0.005814
869 POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL 11 21 0.001091 0.005835
870 REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS 11 21 0.001091 0.005835
871 REGULATION OF POSITIVE CHEMOTAXIS 12 24 0.001108 0.00589
872 STAT CASCADE 20 50 0.001106 0.00589
873 JAK STAT CASCADE 20 50 0.001106 0.00589
874 CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION 12 24 0.001108 0.00589
875 IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY 12 24 0.001108 0.00589
876 AMMONIUM TRANSPORT 22 57 0.001122 0.005959
877 REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 17 40 0.001156 0.006121
878 APICAL JUNCTION ASSEMBLY 17 40 0.001156 0.006121
879 REGULATION OF FILOPODIUM ASSEMBLY 17 40 0.001156 0.006121
880 POSITIVE REGULATION OF CELL ADHESION 101 376 0.001172 0.006199
881 SYNAPTIC VESICLE CYCLE 31 90 0.0012 0.006336
882 CARBOHYDRATE DERIVATIVE METABOLIC PROCESS 252 1047 0.001209 0.006377
883 REGULATION OF CELL JUNCTION ASSEMBLY 25 68 0.001218 0.006419
884 CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION 16 37 0.001283 0.006747
885 IMPORT INTO CELL 16 37 0.001283 0.006747
886 TRANSMISSION OF NERVE IMPULSE 21 54 0.001288 0.006756
887 NITROGEN COMPOUND TRANSPORT 131 507 0.001288 0.006756
888 HAIR CYCLE 29 83 0.00132 0.00691
889 MOLTING CYCLE 29 83 0.00132 0.00691
890 CARBOXYLIC ACID CATABOLIC PROCESS 60 205 0.001327 0.006928
891 ORGANIC ACID CATABOLIC PROCESS 60 205 0.001327 0.006928
892 NEGATIVE REGULATION OF WNT SIGNALING PATHWAY 58 197 0.001356 0.007072
893 PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION 8 13 0.001369 0.007091
894 LIPOPROTEIN TRANSPORT 8 13 0.001369 0.007091
895 LEFT RIGHT AXIS SPECIFICATION 8 13 0.001369 0.007091
896 LIPOPROTEIN LOCALIZATION 8 13 0.001369 0.007091
897 MESENCHYMAL CELL PROLIFERATION 8 13 0.001369 0.007091
898 NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS 8 13 0.001369 0.007091
899 CIRCADIAN RHYTHM 43 137 0.001393 0.007196
900 RESPONSE TO ALKALOID 43 137 0.001393 0.007196
901 ACTIVATION OF MAPK ACTIVITY 43 137 0.001393 0.007196
902 REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS 30 87 0.001399 0.007215
903 ORGAN FORMATION 15 34 0.001412 0.007278
904 REGULATION OF GLUCOSE METABOLIC PROCESS 35 106 0.001417 0.007284
905 ADENYLATE CYCLASE MODULATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY 45 145 0.001415 0.007284
906 POSITIVE REGULATION OF MUSCLE CONTRACTION 18 44 0.001423 0.00731
907 POSITIVE REGULATION OF TRANSPORTER ACTIVITY 27 76 0.001438 0.007379
908 RESPONSE TO RADIATION 109 413 0.001481 0.00759
909 CANONICAL WNT SIGNALING PATHWAY 32 95 0.001538 0.007871
910 NEGATIVE REGULATION OF MOLECULAR FUNCTION 258 1079 0.00156 0.007978
911 NEGATIVE REGULATION OF ADHERENS JUNCTION ORGANIZATION 9 16 0.001633 0.008314
912 POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT 9 16 0.001633 0.008314
913 NEGATIVE REGULATION OF STRESS FIBER ASSEMBLY 9 16 0.001633 0.008314
914 REGULATION OF DEVELOPMENTAL PIGMENTATION 9 16 0.001633 0.008314
915 REGULATION OF SMOOTHENED SIGNALING PATHWAY 23 62 0.001636 0.00832
916 NEURONAL ACTION POTENTIAL 13 28 0.001651 0.008389
917 PANCREAS DEVELOPMENT 26 73 0.001675 0.008497
918 NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION 21 55 0.00169 0.008548
919 POSITIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY 19 48 0.001689 0.008548
920 REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT 19 48 0.001689 0.008548
921 AMINOGLYCAN BIOSYNTHETIC PROCESS 35 107 0.001701 0.008594
922 DOPAMINE METABOLIC PROCESS 12 25 0.00174 0.008742
923 REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION 12 25 0.00174 0.008742
924 POSTSYNAPTIC MEMBRANE ORGANIZATION 12 25 0.00174 0.008742
925 THYROID GLAND DEVELOPMENT 12 25 0.00174 0.008742
926 REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY SARCOPLASMIC RETICULUM 12 25 0.00174 0.008742
927 ENTEROENDOCRINE CELL DIFFERENTIATION 10 19 0.00176 0.008832
928 ENDOCARDIAL CUSHION MORPHOGENESIS 11 22 0.001784 0.008917
929 SYNAPTIC TRANSMISSION GLUTAMATERGIC 11 22 0.001784 0.008917
930 AORTA MORPHOGENESIS 11 22 0.001784 0.008917
931 SUBPALLIUM DEVELOPMENT 11 22 0.001784 0.008917
932 NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS 24 66 0.001798 0.008931
933 POSITIVE REGULATION OF ORGANELLE ORGANIZATION 145 573 0.001804 0.008931
934 REGULATION OF MULTICELLULAR ORGANISM GROWTH 24 66 0.001798 0.008931
935 SUBSTRATE ADHESION DEPENDENT CELL SPREADING 16 38 0.001804 0.008931
936 NEGATIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY 24 66 0.001798 0.008931
937 REGULATION OF RENAL SYSTEM PROCESS 16 38 0.001804 0.008931
938 REGULATION OF CARDIAC CONDUCTION 24 66 0.001798 0.008931
939 RESPONSE TO NUTRIENT 56 191 0.001799 0.008931
940 LENS DEVELOPMENT IN CAMERA TYPE EYE 24 66 0.001798 0.008931
941 MULTI ORGANISM REPRODUCTIVE PROCESS 216 891 0.001818 0.008988
942 REGULATION OF LEUKOCYTE CHEMOTAXIS 32 96 0.001865 0.009211
943 REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS 51 171 0.001883 0.009284
944 REGULATION OF RESPONSE TO NUTRIENT LEVELS 51 171 0.001883 0.009284
945 RESPONSE TO TOXIC SUBSTANCE 68 241 0.001895 0.009332
946 POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE 42 135 0.001898 0.009335
947 PHENOL CONTAINING COMPOUND METABOLIC PROCESS 28 81 0.001903 0.00934
948 POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING 28 81 0.001903 0.00934
949 ENDOTHELIAL CELL DEVELOPMENT 18 45 0.001928 0.009384
950 METENCEPHALON DEVELOPMENT 33 100 0.001928 0.009384
951 PROTEIN LOCALIZATION TO CELL PERIPHERY 46 151 0.00192 0.009384
952 ORGANIC HYDROXY COMPOUND TRANSPORT 47 155 0.001917 0.009384
953 THYMOCYTE AGGREGATION 18 45 0.001928 0.009384
954 T CELL DIFFERENTIATION IN THYMUS 18 45 0.001928 0.009384
955 SMOOTH MUSCLE CONTRACTION 18 45 0.001928 0.009384
956 PEPTIDYL TYROSINE DEPHOSPHORYLATION 33 100 0.001928 0.009384
957 NEURAL PRECURSOR CELL PROLIFERATION 25 70 0.00195 0.00947
958 REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 25 70 0.00195 0.00947
959 RESPONSE TO CAMP 34 104 0.001984 0.009627
960 REGULATION OF GLYCOGEN METABOLIC PROCESS 15 35 0.002013 0.009747
961 RESPONSE TO MONOAMINE 15 35 0.002013 0.009747
962 MUCOPOLYSACCHARIDE METABOLIC PROCESS 35 108 0.002034 0.009836
NumGOOverlapSizeP ValueAdj. P Value
1 RNA POLYMERASE II TRANSCRIPTION FACTOR ACTIVITY SEQUENCE SPECIFIC DNA BINDING 221 629 9.787e-19 5.017e-16
2 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 136 328 1.08e-18 5.017e-16
3 NUCLEIC ACID BINDING TRANSCRIPTION FACTOR ACTIVITY 360 1199 9.405e-17 2.912e-14
4 REGULATORY REGION NUCLEIC ACID BINDING 258 818 6.083e-15 1.173e-12
5 RECEPTOR BINDING 419 1476 6.314e-15 1.173e-12
6 ENZYME BINDING 474 1737 1.251e-13 1.936e-11
7 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 120 315 1.767e-13 2.346e-11
8 DOUBLE STRANDED DNA BINDING 238 764 3.142e-13 3.649e-11
9 TRANSCRIPTIONAL ACTIVATOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 93 226 5.39e-13 5.564e-11
10 MOLECULAR FUNCTION REGULATOR 379 1353 1.1e-12 1.022e-10
11 PROTEIN KINASE ACTIVITY 204 640 1.542e-12 1.303e-10
12 SEQUENCE SPECIFIC DNA BINDING 301 1037 3.52e-12 2.697e-10
13 CORE PROMOTER PROXIMAL REGION DNA BINDING 132 371 3.774e-12 2.697e-10
14 KINASE ACTIVITY 248 842 6.456e-11 4.179e-09
15 GROWTH FACTOR BINDING 57 123 6.747e-11 4.179e-09
16 RIBONUCLEOTIDE BINDING 485 1860 1.356e-10 7.876e-09
17 GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 108 303 2.999e-10 1.639e-08
18 ADENYL NUCLEOTIDE BINDING 403 1514 3.855e-10 1.99e-08
19 MACROMOLECULAR COMPLEX BINDING 376 1399 4.532e-10 2.216e-08
20 CALCIUM ION BINDING 207 697 1.197e-09 5.296e-08
21 PROTEIN DOMAIN SPECIFIC BINDING 189 624 1.17e-09 5.296e-08
22 RECEPTOR SIGNALING PROTEIN ACTIVITY 69 172 1.887e-09 7.969e-08
23 RAS GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 85 228 1.975e-09 7.977e-08
24 NUCLEOSIDE TRIPHOSPHATASE REGULATOR ACTIVITY 112 329 3.042e-09 1.178e-07
25 TRANSMEMBRANE RECEPTOR PROTEIN KINASE ACTIVITY 40 81 4.632e-09 1.721e-07
26 PROTEIN SERINE THREONINE KINASE ACTIVITY 141 445 6.805e-09 2.431e-07
27 ENZYME ACTIVATOR ACTIVITY 147 471 9.909e-09 3.409e-07
28 IDENTICAL PROTEIN BINDING 324 1209 1.108e-08 3.677e-07
29 CYTOSKELETAL PROTEIN BINDING 232 819 1.211e-08 3.879e-07
30 TRANSFERASE ACTIVITY TRANSFERRING PHOSPHORUS CONTAINING GROUPS 271 992 2.951e-08 9.138e-07
31 KINASE BINDING 177 606 6.989e-08 2.094e-06
32 LIPID BINDING 189 657 8.465e-08 2.457e-06
33 CELL ADHESION MOLECULE BINDING 68 186 1.861e-07 5.24e-06
34 GLYCOSAMINOGLYCAN BINDING 73 205 2.252e-07 6.152e-06
35 SULFUR COMPOUND BINDING 80 234 4.27e-07 1.134e-05
36 PROTEIN KINASE A BINDING 23 42 8.437e-07 2.139e-05
37 ENZYME REGULATOR ACTIVITY 255 959 8.521e-07 2.139e-05
38 SMAD BINDING 33 72 9.11e-07 2.227e-05
39 PROTEIN COMPLEX BINDING 249 935 1.01e-06 2.347e-05
40 CHROMATIN BINDING 130 435 1.003e-06 2.347e-05
41 TRANSCRIPTION FACTOR BINDING 151 524 1.495e-06 3.386e-05
42 PDZ DOMAIN BINDING 38 90 1.774e-06 3.925e-05
43 GROWTH FACTOR ACTIVITY 58 160 1.967e-06 4.25e-05
44 PHOSPHOLIPID BINDING 110 360 2.137e-06 4.512e-05
45 PROTEIN DIMERIZATION ACTIVITY 296 1149 2.186e-06 4.514e-05
46 HEPARIN BINDING 57 157 2.271e-06 4.586e-05
47 PROTEIN HOMODIMERIZATION ACTIVITY 197 722 2.564e-06 5.068e-05
48 TRANSFORMING GROWTH FACTOR BETA RECEPTOR BINDING 25 50 2.655e-06 5.138e-05
49 PHOSPHOLIPID TRANSLOCATING ATPASE ACTIVITY 12 16 3.82e-06 7.243e-05
50 TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY 29 64 5.452e-06 0.0001013
51 ACTIN BINDING 116 393 7.138e-06 0.0001275
52 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 49 133 7.106e-06 0.0001275
53 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II CORE PROMOTER PROXIMAL REGION SEQUENCE SPECIFIC BINDING 41 105 7.585e-06 0.000133
54 ZINC ION BINDING 293 1155 9.326e-06 0.0001604
55 TRANSMEMBRANE TRANSPORTER ACTIVITY 257 997 9.863e-06 0.0001666
56 RECEPTOR SERINE THREONINE KINASE BINDING 11 15 1.425e-05 0.0002364
57 RHO GUANYL NUCLEOTIDE EXCHANGE FACTOR ACTIVITY 32 77 1.677e-05 0.0002733
58 METAL ION TRANSMEMBRANE TRANSPORTER ACTIVITY 120 417 1.84e-05 0.0002947
59 TRANSITION METAL ION BINDING 345 1400 2.221e-05 0.0003497
60 COLLAGEN BINDING 28 65 2.524e-05 0.0003907
61 ATPASE ACTIVITY COUPLED TO MOVEMENT OF SUBSTANCES 44 121 2.957e-05 0.0004504
62 PASSIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 130 464 3.408e-05 0.0005107
63 TRANSFORMING GROWTH FACTOR BETA BINDING 11 16 3.719e-05 0.0005484
64 VOLTAGE GATED ION CHANNEL ACTIVITY 62 190 4.093e-05 0.0005942
65 PHOSPHATIDYLINOSITOL 3 KINASE ACTIVITY 29 70 4.402e-05 0.0006292
66 GLUCOCORTICOID RECEPTOR BINDING 10 14 5.201e-05 0.0007212
67 TRANSCRIPTION FACTOR ACTIVITY RNA POLYMERASE II CORE PROMOTER SEQUENCE SPECIFIC 10 14 5.201e-05 0.0007212
68 CHEMOREPELLENT ACTIVITY 15 27 5.617e-05 0.0007674
69 TRANSCRIPTION FACTOR ACTIVITY DIRECT LIGAND REGULATED SEQUENCE SPECIFIC DNA BINDING 22 48 5.861e-05 0.0007891
70 PHOSPHATIDYLINOSITOL BINDING 64 200 6.029e-05 0.0008002
71 CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY 45 128 6.256e-05 0.0008186
72 GATED CHANNEL ACTIVITY 95 325 6.913e-05 0.0008797
73 HYDROLASE ACTIVITY ACTING ON ACID ANHYDRIDES 211 820 6.833e-05 0.0008797
74 GROWTH FACTOR RECEPTOR BINDING 45 129 7.741e-05 0.0009608
75 TRANSPORTER ACTIVITY 313 1276 7.757e-05 0.0009608
76 ION CHANNEL BINDING 40 111 8.398e-05 0.001024
77 TRANSCRIPTION FACTOR ACTIVITY PROTEIN BINDING 157 588 8.599e-05 0.001024
78 TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE ACTIVITY 11 17 8.598e-05 0.001024
79 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION REGULATORY REGION SEQUENCE SPECIFIC BINDING 55 168 9.792e-05 0.001151
80 PROTEIN TYROSINE KINASE ACTIVITY 57 176 0.000103 0.001197
81 PROTEIN KINASE A CATALYTIC SUBUNIT BINDING 10 15 0.0001275 0.001463
82 CATION CHANNEL ACTIVITY 87 298 0.0001429 0.001618
83 ACTIVATING TRANSCRIPTION FACTOR BINDING 24 57 0.0001447 0.001619
84 RECEPTOR SIGNALING PROTEIN SERINE THREONINE KINASE ACTIVITY 34 92 0.0001584 0.001752
85 DIVALENT INORGANIC CATION TRANSMEMBRANE TRANSPORTER ACTIVITY 54 167 0.0001616 0.001766
86 INSULIN RECEPTOR BINDING 16 32 0.0001687 0.001822
87 PHOSPHOLIPID TRANSPORTER ACTIVITY 21 48 0.0001945 0.002077
88 RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 37 104 0.0002053 0.002167
89 SCAFFOLD PROTEIN BINDING 20 45 0.0002119 0.002187
90 TRANSCRIPTIONAL REPRESSOR ACTIVITY RNA POLYMERASE II TRANSCRIPTION FACTOR BINDING 32 86 0.000211 0.002187
91 ACTIVE TRANSMEMBRANE TRANSPORTER ACTIVITY 100 356 0.0002341 0.00239
92 GLYCOPROTEIN BINDING 36 101 0.0002382 0.002405
93 SH3 DOMAIN BINDING 40 116 0.0002486 0.002483
94 STEROID HORMONE RECEPTOR ACTIVITY 24 59 0.0002725 0.002693
95 PROTEIN KINASE A REGULATORY SUBUNIT BINDING 10 16 0.0002781 0.002711
96 KINASE REGULATOR ACTIVITY 58 186 0.0002802 0.002711
97 ATPASE ACTIVITY COUPLED 89 313 0.000323 0.003094
98 X1 PHOSPHATIDYLINOSITOL BINDING 11 19 0.0003501 0.003318
99 CYTOKINE BINDING 33 92 0.0003719 0.00349
100 METALLOPEPTIDASE ACTIVITY 58 188 0.0003808 0.003537
101 SEMAPHORIN RECEPTOR BINDING 12 22 0.0003976 0.003657
102 PHOSPHATASE BINDING 51 162 0.0004933 0.004493
103 ATPASE ACTIVITY 115 427 0.0005055 0.004559
104 PHOSPHATIDYLINOSITOL PHOSPHATE BINDING 39 116 0.000526 0.004685
105 CORE PROMOTER SEQUENCE SPECIFIC DNA BINDING 35 101 0.0005295 0.004685
106 HISTONE DEACETYLASE BINDING 36 105 0.000559 0.004854
107 INTEGRIN BINDING 36 105 0.000559 0.004854
108 HORMONE BINDING 25 65 0.0005651 0.004861
109 EXTRACELLULAR MATRIX STRUCTURAL CONSTITUENT 28 76 0.0006147 0.005239
110 VOLTAGE GATED SODIUM CHANNEL ACTIVITY 11 20 0.0006356 0.005319
111 EXTRACELLULAR GLUTAMATE GATED ION CHANNEL ACTIVITY 11 20 0.0006356 0.005319
112 KINASE ACTIVATOR ACTIVITY 24 62 0.0006483 0.005377
113 CORE PROMOTER BINDING 48 152 0.0006575 0.005406
114 GTPASE BINDING 83 295 0.0007161 0.005836
115 X3 5 CYCLIC AMP PHOSPHODIESTERASE ACTIVITY 9 15 0.000871 0.006901
116 ICOSANOID RECEPTOR ACTIVITY 9 15 0.000871 0.006901
117 ORGANIC ACID TRANSMEMBRANE TRANSPORTER ACTIVITY 45 142 0.0008765 0.006901
118 PLATELET DERIVED GROWTH FACTOR RECEPTOR BINDING 9 15 0.000871 0.006901
119 SIGNALING ADAPTOR ACTIVITY 27 74 0.0009061 0.007074
120 CHANNEL REGULATOR ACTIVITY 42 131 0.0009874 0.007644
121 SYNTAXIN 1 BINDING 10 18 0.001018 0.007687
122 HMG BOX DOMAIN BINDING 10 18 0.001018 0.007687
123 TUBULIN BINDING 77 273 0.001009 0.007687
124 MAGNESIUM ION BINDING 59 199 0.00103 0.007716
125 TRANSCRIPTION COFACTOR BINDING 12 24 0.001108 0.008232
126 PROTEIN COMPLEX SCAFFOLD 25 68 0.001218 0.008981
127 PROTEIN TYROSINE KINASE BINDING 21 54 0.001288 0.00942
128 LOW DENSITY LIPOPROTEIN RECEPTOR ACTIVITY 8 13 0.001369 0.009932
NumGOOverlapSizeP ValueAdj. P Value
1 SYNAPSE 281 754 3.566e-28 1.668e-25
2 CELL PROJECTION 548 1786 5.714e-28 1.668e-25
3 CELL JUNCTION 382 1151 2.598e-26 5.057e-24
4 NEURON PART 406 1265 1.031e-24 1.505e-22
5 NEURON PROJECTION 320 942 5.94e-24 6.938e-22
6 SYNAPSE PART 221 610 1.434e-20 1.396e-18
7 MEMBRANE REGION 355 1134 1.183e-19 9.872e-18
8 PROTEINACEOUS EXTRACELLULAR MATRIX 144 356 1.48e-18 1.027e-16
9 PLASMA MEMBRANE REGION 299 929 1.583e-18 1.027e-16
10 SOMATODENDRITIC COMPARTMENT 224 650 7.586e-18 4.43e-16
11 EXTRACELLULAR MATRIX 162 426 1.224e-17 6.5e-16
12 INTRINSIC COMPONENT OF PLASMA MEMBRANE 471 1649 2.991e-17 1.456e-15
13 POSTSYNAPSE 146 378 1.056e-16 4.746e-15
14 CELL PROJECTION PART 295 946 3.284e-16 1.37e-14
15 EXTRACELLULAR MATRIX COMPONENT 64 125 1.369e-14 5.33e-13
16 DENDRITE 160 451 2.584e-14 9.43e-13
17 EXCITATORY SYNAPSE 85 197 2.362e-13 8.114e-12
18 AXON 147 418 6.414e-13 2.081e-11
19 CELL BODY 165 494 3.464e-12 1.065e-10
20 CELL CELL JUNCTION 135 383 4.657e-12 1.36e-10
21 ANCHORING JUNCTION 161 489 2.271e-11 6.314e-10
22 CELL LEADING EDGE 123 350 5.156e-11 1.369e-09
23 BASEMENT MEMBRANE 46 93 3.084e-10 7.83e-09
24 APICAL PART OF CELL 120 361 4.21e-09 1.025e-07
25 SYNAPTIC MEMBRANE 93 261 5.124e-09 1.197e-07
26 T TUBULE 27 45 6.477e-09 1.455e-07
27 APICAL PLASMA MEMBRANE 101 292 6.983e-09 1.51e-07
28 CELL SUBSTRATE JUNCTION 128 398 1.253e-08 2.613e-07
29 GOLGI APPARATUS 376 1445 2.634e-08 5.304e-07
30 MEMBRANE MICRODOMAIN 98 288 2.957e-08 5.757e-07
31 APICAL JUNCTION COMPLEX 53 128 3.918e-08 7.381e-07
32 CYTOPLASMIC REGION 97 287 5.056e-08 9.227e-07
33 RECEPTOR COMPLEX 107 327 7.173e-08 1.269e-06
34 AXON PART 78 219 8.742e-08 1.502e-06
35 SARCOLEMMA 51 125 1.235e-07 2.06e-06
36 ACTIN BASED CELL PROJECTION 67 181 1.33e-07 2.151e-06
37 PLASMA MEMBRANE RAFT 39 86 1.363e-07 2.151e-06
38 PLASMA MEMBRANE PROTEIN COMPLEX 152 510 1.511e-07 2.322e-06
39 CELL SURFACE 211 757 2.126e-07 3.184e-06
40 FILOPODIUM 41 94 2.451e-07 3.578e-06
41 PRESYNAPSE 92 283 7.932e-07 1.13e-05
42 PERINUCLEAR REGION OF CYTOPLASM 179 642 1.728e-06 2.403e-05
43 SITE OF POLARIZED GROWTH 55 149 1.882e-06 2.502e-05
44 CELL CORTEX 79 238 1.885e-06 2.502e-05
45 NEURON SPINE 47 121 2.014e-06 2.614e-05
46 CATION CHANNEL COMPLEX 59 167 4.157e-06 5.278e-05
47 ENDOPLASMIC RETICULUM 401 1631 5.839e-06 7.255e-05
48 PRESYNAPTIC ACTIVE ZONE 17 29 6.703e-06 8.155e-05
49 POSTSYNAPTIC MEMBRANE 68 205 9.726e-06 0.0001159
50 NEURONAL POSTSYNAPTIC DENSITY 25 53 1.001e-05 0.0001169
51 LAMELLIPODIUM 59 172 1.18e-05 0.0001351
52 NEURON PROJECTION TERMINUS 47 129 1.519e-05 0.0001706
53 NEURON PROJECTION MEMBRANE 19 36 1.552e-05 0.000171
54 GLYCOPROTEIN COMPLEX 13 21 3.763e-05 0.0004069
55 NEUROMUSCULAR JUNCTION 24 54 5.096e-05 0.0005411
56 VOLTAGE GATED SODIUM CHANNEL COMPLEX 10 14 5.201e-05 0.0005424
57 I BAND 43 121 6.765e-05 0.0006931
58 CELL PROJECTION MEMBRANE 88 298 8.454e-05 0.0008513
59 BASOLATERAL PLASMA MEMBRANE 66 211 0.0001006 0.0009646
60 LEADING EDGE MEMBRANE 46 134 0.0001007 0.0009646
61 CONTRACTILE FIBER 66 211 0.0001006 0.0009646
62 ACTIN FILAMENT 28 70 0.0001236 0.001164
63 ACTIN CYTOSKELETON 122 444 0.0001441 0.001295
64 COMPLEX OF COLLAGEN TRIMERS 13 23 0.0001402 0.001295
65 INTRACELLULAR VESICLE 307 1259 0.0001427 0.001295
66 PLASMA MEMBRANE RECEPTOR COMPLEX 56 175 0.0001682 0.001489
67 PLATELET ALPHA GRANULE 29 75 0.0001907 0.001662
68 GOLGI APPARATUS PART 224 893 0.0002129 0.001829
69 TRANSPORTER COMPLEX 91 321 0.0003116 0.002637
70 VACUOLE 286 1180 0.0003643 0.003039
71 CELL CELL ADHERENS JUNCTION 22 54 0.0004713 0.003876
72 PERIKARYON 37 108 0.0004802 0.003895
73 SODIUM CHANNEL COMPLEX 10 17 0.0005526 0.004421
74 CYTOSKELETON 455 1967 0.0006099 0.004813
75 COLLAGEN TRIMER 31 88 0.0007842 0.006107
76 COATED PIT 25 67 0.0009512 0.007309
77 CELL CELL CONTACT ZONE 24 64 0.001099 0.00823
78 TERMINAL BOUTON 24 64 0.001099 0.00823
79 VOLTAGE GATED CALCIUM CHANNEL COMPLEX 17 40 0.001156 0.008549
80 PROTEIN KINASE COMPLEX 31 90 0.0012 0.008758
81 DENDRITIC SHAFT 16 37 0.001283 0.009253

Over-represented Pathway

NumPathwayPathviewOverlapSizeP ValueAdj. P Value
1 MAPK_signaling_pathway_hsa04010 108 295 4.857e-11 2.525e-09
2 TGF_beta_signaling_pathway_hsa04350 42 84 1.18e-09 3.068e-08
3 Rap1_signaling_pathway_hsa04015 78 206 4.007e-09 5.264e-08
4 Focal_adhesion_hsa04510 76 199 4.049e-09 5.264e-08
5 PI3K_Akt_signaling_pathway_hsa04151 117 352 6.584e-09 6.847e-08
6 Hippo_signaling_pathway_hsa04390 61 154 2.8e-08 2.427e-07
7 Ras_signaling_pathway_hsa04014 79 232 6.034e-07 4.483e-06
8 Gap_junction_hsa04540 38 88 9.052e-07 5.261e-06
9 Signaling_pathways_regulating_pluripotency_of_stem_cells_hsa04550 53 139 9.106e-07 5.261e-06
10 cAMP_signaling_pathway_hsa04024 69 198 1.181e-06 6.143e-06
11 cGMP_PKG_signaling_pathway_hsa04022 59 163 1.704e-06 8.056e-06
12 FoxO_signaling_pathway_hsa04068 50 132 2.29e-06 9.924e-06
13 Calcium_signaling_pathway_hsa04020 61 182 1.908e-05 7.633e-05
14 Adherens_junction_hsa04520 30 72 2.869e-05 0.0001066
15 Phospholipase_D_signaling_pathway_hsa04072 50 146 5.529e-05 0.0001917
16 Regulation_of_actin_cytoskeleton_hsa04810 65 208 0.0001165 0.0003787
17 Apelin_signaling_pathway_hsa04371 46 137 0.0001819 0.0005452
18 ECM_receptor_interaction_hsa04512 31 82 0.0001887 0.0005452
19 Wnt_signaling_pathway_hsa04310 48 146 0.0002349 0.0006429
20 ABC_transporters_hsa02010 19 45 0.0006666 0.001733
21 Neuroactive_ligand_receptor_interaction_hsa04080 76 278 0.002714 0.00672
22 mTOR_signaling_pathway_hsa04150 45 151 0.00341 0.008059
23 ErbB_signaling_pathway_hsa04012 28 85 0.004192 0.009477
24 Phosphatidylinositol_signaling_system_hsa04070 31 99 0.006258 0.01279
25 p53_signaling_pathway_hsa04115 23 68 0.006263 0.01279
26 Endocytosis_hsa04144 66 244 0.006394 0.01279
27 Tight_junction_hsa04530 48 170 0.007941 0.01529
28 Cytokine_cytokine_receptor_interaction_hsa04060 71 270 0.009738 0.01809
29 AMPK_signaling_pathway_hsa04152 35 121 0.01454 0.02606
30 Hippo_signaling_pathway_multiple_species_hsa04392 11 29 0.0217 0.03762
31 HIF_1_signaling_pathway_hsa04066 29 100 0.02363 0.03963
32 Cellular_senescence_hsa04218 43 160 0.02653 0.04312
33 Sphingolipid_signaling_pathway_hsa04071 33 118 0.02791 0.04398
34 Jak_STAT_signaling_pathway_hsa04630 43 162 0.03226 0.04891
35 Cell_adhesion_molecules_.CAMs._hsa04514 39 145 0.03292 0.04891
36 TNF_signaling_pathway_hsa04668 30 108 0.03785 0.05468
37 Autophagy_animal_hsa04140 34 128 0.05163 0.07256
38 Oocyte_meiosis_hsa04114 33 124 0.05327 0.0729
39 Mitophagy_animal_hsa04137 19 65 0.05473 0.07298
40 Peroxisome_hsa04146 22 83 0.1035 0.1345
41 Apoptosis_multiple_species_hsa04215 10 33 0.1148 0.1449
42 Cell_cycle_hsa04110 31 124 0.117 0.1449
43 Hedgehog_signaling_pathway_hsa04340 13 47 0.1414 0.171
44 Apoptosis_hsa04210 32 138 0.2254 0.2664
45 Ferroptosis_hsa04216 9 40 0.4247 0.4907
46 Notch_signaling_pathway_hsa04330 10 48 0.5196 0.5874
47 Autophagy_other_hsa04136 6 32 0.6548 0.7245
48 VEGF_signaling_pathway_hsa04370 11 59 0.6737 0.7298
49 Phagosome_hsa04145 27 152 0.8087 0.8582
50 Necroptosis_hsa04217 26 164 0.9386 0.9636
51 Lysosome_hsa04142 18 123 0.9576 0.9636
52 NF_kappa_B_signaling_pathway_hsa04064 13 95 0.9636 0.9636

Quest ID: 279fe43abdb3fd19b41c9e84088e4130